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ABSTRACT 
Skeletal tissue has the unique ability to regenerate instead of heal by 
scarring. This regeneration potential of the bone tissue is manifested in the process 
of fracture repair. The discovery of distraction osteogenesis pushes the regeneration 
potential of the skeletal tissue one-step further. In fracture healing, the pieces of 
bone at the fracture site are reunited and returned to normal function without any 
intervention of tensile force. In distraction osteogenesis, the skeletal tissue is not 
only reunited but also generates a massive amount of new bone between the 
osteotomy site under a tensile force. 
In this study, expressions of the different bone formation markers and bone-
derived growth factors during fracture healing and distraction osteogenesis in goats 
were investigated. The different biochemical events in distraction osteogenesis were 
compared with that in fracture healing. This comparison provided information on the 
in vivo effect of tensile force on osseous tissue in term of the tested parameters. 
The biochemical markers examined in this study were bone-specific alkaline 
phosphatase (BALP) and osteocalcin. During fracture healing, the BALP activity 
gradually elevated from week 1 to week 5 post-fracture and then dropped back to the 
baseline at week 6 post-fracture. In distraction osteogenesis, the BALP activity 
increased during the distraction period (week 1 to week 5) and the high level 
sustained for four more weeks after distraction had stopped. For the osteocalcin 
measurement in fracture healing, a raising trend was observed from week 1 to week 
12 post-fracture. Unlike fracture healing, the osteocalcin concentration was below 
the baseline during the course ofdistraction osteogenesis. 
In addition to the measurement of biochemical markers, protein expressions 
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of the three different growth factors, aFGF, bFGF, and TGF_pi, in the reparative and 
regenerative processes were examined by immunohistochemistry. During the 
chondrogenesis and the endochondral ossification stages of fracture healing, strong 
staining of the three growth factors was found in the chondrocytes at the edge of the 
cartilaginous tissue. Strong aFGF was found in osteocytes located at the fractured 
callus and distraction callus. 
During fracture healing, bFGF expression was localized at the osteoblasts 
and the mesenchymal cells in the ossification center of the external callus. The 
staining of these cells was strong in the first three weeks after fracture. The 
periosteal cells stained moderately for bFGF at the first two weeks post-fracture. In 
distraction osteogenesis, localization of bFGF in the distraction callus was similar to 
that in fracture healing. The osteoblasts and the pre-osteoblasts in the distraction 
callus exhibited strong staining in the latency and the distraction period. The 
fibroblast-like mesenchymal cells were stained moderately for bFGF. 
The immunohistochemistry studies on the fracture healing process revealed 
that the osteoblasts and the mesenchymal cells at the ossification center of the 
intramembranous ossification stained strongly for TGF_pi. This expression declined 
progressively. At week 8 post-fracture, the staining for TGF-pl became also non-
existent. In distraction osteogenesis, trabecular bone formed around the cortex of the 
osteotomy site and strong TGF_pi staining in osteoblasts and pre-osteoblasts of the 
newly formed woven bone was observed in the first week. This strong staining 
persisted at the osteoblasts and the pre-osteoblasts during the distraction period. The 
fibroblast-like mesenchymal cells at the fibrous tissue of the distraction callus 
exhibited moderate TGF_pi staining during the distraction period. After distraction, 
the TGF-pi staining was subsided at the osteoblasts, per-osteoblasts and the 
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mesenchymal cells of the distraction callus. 
The effect of the tensile force in bone regeneration can be investigated by 
comparing fracture healing and distraction osteogenesis since the difference between 
these two processes lies in the application of the tensile force on osseous tissue 
during the distraction. In conclusion, immunohistochemistry of the growth factors 
showed that the tensile force could up-regulate the expression of these growth 
factors. The upregulated expression of growth factors promoted differentiation ofthe 
mesenchymal cells. These growth factors also stimulated the osteoblasts to 
proliferate and to increase bone-forming activity. Thus, the BMD increased rapidly 
from the last week of the distraction period to the third week after the distraction had 
stopped. The path of the mechanical stimulation resulting in stimulating the increase 














愈合中，B A L P活性在骨折後 1至 5週逐漸升高，在骨折後 6週降回基線水平。 
在牽離誘導成骨過程中，B A L P在牵引分離期 ( 1一 5週 )升高’並且維持至停止 
牽引後 4週。至於骨釣素，則在骨折後 1至 1 2週呈升高趨勢，但其在牽離誘 
導成骨過程中卻一直保持在基線以下° 
同時亦應用多克隆抗體免疫組織化學方法檢測三種不同的生長因子（aFGF, 
b F G F和T G F - M )在骨折修復和骨再生過程中的表達。在骨折愈合中的軟骨成 
骨及軟骨內骨化階段，在軟骨組織周邊的軟骨細胞，三種生長因子呈強陽性表 
達。而a F G F在骨折處骨:>^及牽離誘導成骨處骨痴中的骨細胞上強陽性表達。 
在骨折愈合過程中 ' b F G F 在成骨細胞和外骨恭骨化中心的間質細胞中表 
vi 
達，並且在骨折最初三週呈強陽性表達 °同時骨折後最初二週 ’ b F G F亦在骨 
膜細胞中呈中等強度表達 °在牽離誘導成骨過程中， b F G F在牽離誘導成骨骨 
恭中的表達與骨折骨：痴中的表達相似°在牽離誘導潛伏期和牽離期 ’ b F G F 在 
誘導骨-痴中的成骨細胞和成骨母細胞中呈強陽性表達，在成纖維細胞樣的間質 
細胞中呈中等程度表達。 
在骨折愈合中 ' T G F - b l在膜内骨化中心的成骨細胞和間質細胞中呈強陽 
表達，並逐漸降低。骨折後 8週， b F G F - M的表達變弱。在牽離誘導成骨中， 
截骨端骨皮質周圍已形成骨小樑。在新骨形成的第一週 ’ T G F - b l在成骨細胞 
和成骨母細胞中呈強陽性表達’並維持整個牽離時期°同時在此時期，T G F - b l 
在誘導骨：麻纖維組織中的成纖維細胞樣間質細胞上呈中度表達 °在牽離後， 
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Skeletal tissue has the unique ability to regenerate instead of heal by 
scarring. This regeneration potential of bone tissue is manifested in the process of 
fracture repair. The discovery of distraction osteogenesis pushes the regeneration 
potential of skeletal tissue one-step further. In fracture healing, the pieces of bone at 
the fracture site are reunited and returned to normal function without any 
intervention of tensile force. In distraction osteogenesis, the skeletal tissue not only 
reunites but also generates a massive amount of new bone between the osteotomy 
site under a tensile force. The generated new bone is remodeled and returned to 
normal function as part of fracture healing process. The difference between these 
two processes lies in the application of tensile force at the fracture site. Better 
understanding of the effect of the tensile force application can be achieved by 
studying the biochemical responses, cellular and molecular basis, and the local 
factors released at the fracture or osteotomy site. 
In this study, different biochemical markers and growth factors were 
measured to understand the stimulating effect of the tensile force on bone formation. 
First, the formation of bone at the osteotomy or the distraction site in term of the 
mineralization of the newly generated tissue was monitored by the measuring the 
bone mineral density through plain radiographs. During fracture healing and 
distraction osteogenesis, new bone is formed at the osteotomy site. It implies that the 
osteoblastic activity can be elevated. Bone-specific alkaline phosphatase plays an 
important role in skeletal mineralization (Anderson, 1989), so its activity in serum 
can provide a better understanding of the cellular events in the both reparative and 
regeneration process. In addition, osteocalcin is another protein involved in the 
2 
Introduction 
formation of bony tissue. It is one of the most abundant non-collagenous structural 
proteins in bone and has specific calcium binding property (Hauschka et al., 1975). 
Therefore, serum osteocalcin concentrations were assessed to provide the 
information on the biosynthesis of the new bone. Besides from the structural 
proteins, bone matrix also contains small amounts of very potent regulators of bone 
cell metabolism. These proteins, called bone-derived growth factors, are produced 
by osteoblasts, chondrocytes, or mesenchymal cells and incorporated into the 
extracellular matrix during bone formation. The bone growth factors exhibit 
paracrine or autocrine effects in the local cellular environment to regulate the 
proliferation and differentiation of cells and the synthesis of matrix protein 
(Korhonen and Vaananen, 1992). Understanding of the local expression of the bone 
growth factors during distraction osteogenesis and fracture healing will give us more 
information on the regulation of bone formation under mechanical strain. Acidic 
fibroblast growth factor, basic fibroblast growth factor and transforming growth 
factor-pi were chosen in this study since they were among the most abundant growth 
factors in bone and widely studied in other systems. 
1.1. History of Distraction Osteogenesis 
Back in 1905, Codivilla had described the use of an osteotomy of the cortex 
and immediate application of traction force to a calcaneal pin, with or without the use 
of narcotics. He was the first one to report the successful lengthening of deformed 
limbs. In 1908，Magnuson studied the potential for spontaneous bone healing in an 
experimental study involving sixteen dogs and, in 1913, presented three clinical case 
reports. At the same year, Ombredanne, who was the first to use an external fixator 
for limb lengthening, reported lengthening of bone at a rate of five millimeters per 
i 
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day after the production of an oblique osteotomy of the femur. In the development of 
distraction osteogenesis, the idea of a latency period to promote the formation of 
bone was introduced by Abbott in 1927. Abbott performed a step-cut osteotomy, 
with preservation of the periosteum, and then allowed a seven-to-ten-day latency 
period before applying distraction. Later in 1942, Brockway and Fowler reported the 
long-term results of 105 cases of limb lengthening operation using Abbott's 
technique. Other major advances have included osteotomy with preservation of the 
periosteum (Anderson, 1952; Coleman and Noonan, 1967) and the development of 
small, strong fixators that permit mobilization of the patients (Wagner, 1978). 
Although the advance was paramount in the field, the modem technique is credited 
to Professor G.A. Ilizarov. He had performed extensive studies on limb lengthening 
(distraction osteogenesis) to give the majority of information concerning the biology 
of the new bone formation during limb lengthening. He also developed the circular 
external fixator that now bears his name and elucidated a number of important 
principles of distraction osteogenesis, which were sometime known as the Ilizarov 
method. His method involves the followings: 
1. Preservation of the periosteum, endosteum and bone marrow by 
corticotomy 
2. Stable external fixation 
3. Delay before distraction to allow first stage of fracture healing (Latency 
Period) 
4. Slow high frequency distraction (not exceeding 1 mm / day) 
5. Functional use of the limb in external fixator stimulates callus formation 
and ossification of regenerate 
4 
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1.2. Clinical Application of Distraction Osteogenesis 
The Ilizarov method has made important contributions to three areas of 
orthopaedics, which are limb lengthening, treatment of deformity or non-union, and 
bone transport. In 1992, Joseph McCarthy adapted the Ilizarov's method to its 
eventual application in the craniofacial complex. 
1.2.1. Limb-Lengthening 
The Ilizarov method allows the surgeon to perform complex and extends 
lengthening of both congenital and acquired short limbs. For example, certain 
congenital conditions, such as fibular hemimelia and proximal femoral focal 
deficiency in their severe forms, have traditionally necessitated amputation with 
early prosthetic fitting (Renzi-Brivio et al., 1990). Grill and Dungl (1991) reported 
lengthening of as much as sixteen centimeters of femur in patients who had severe 
forms of proximal femoral focal deficiency and an intact hipjoint. Disorders related 
to short stature, including achondroplastic dwarfs, endocrine and osteochondral 
dysplasias, have been treated with lengthening in Europe and the United States. 
The Ilizarov method has advanced limb lengthening in several ways. First, 
it is now possible to lengthen limbs at several sites simultaneously as well as to 
correct deformity. In addition, since the method allows for gradual lengthening with 
protection of adjacentjoints in a frame that permits most activities of daily living, the 
possibilities of limb lengthening have been extended. Perhaps most importantly, 
large skeletal defects can heal without bone-grafting, internal fixation, or multiple 
operations (Aronson, 1997). 
1.2.2. Correction of Deformities and Non-Unions 
The treatment of limb deformities requires meticulous analysis of the 
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clinical and radiographic features to determine the true deformity. The Ilizarov 
method gives surgeons the option of correcting osseous deformity and soft-tissue 
contracture acutely or gradually, or both. It has even been possible to correct 
deformities in certain types of pathologically involved bone (Eyres et al., 1993), 
including that seen in melorheostosis (Atar et al., 1992; Moens et al., 1995; Stanitski, 
1994). 
Ilizarov differentiated between hypertrophic and atrophic types of non-
unions based on clinical and radiographic findings to determine the treatment 
strategy that would facilitate healing, and he proposed specific methods of treatment 
for each type. Hypertrophic and atrophic type non-unions have a vital blood supply 
from each bone end and a dense collagenous interface. For these reasons, bone 
formation can be stimulated by primary distraction. In a study by Catagni et al. 
(1994)，a stable union and correction of the deformities were achieved in all patients. 
In another case, atrophic tibial non-unions were treated initially with compression 
and then with distraction. Union was achieved in many patients (Paley et al., 1989). 
1.2.3. Bone Transport 
Intercalary defects resulting from trauma, infection, tumor, or prosthetic 
replacement can be treated with transport of a segment of bone within the limb 
(Ilizarov, 1992). The method of bone transport is perhaps the most unique of 
Ilizarov's innovations. Bone grafts have not been necessary in many patients, and 
limb length has been regained. For example, the osteomyelitic bone is excised, and 
generation ofbone is induced in the resultant defect (Aronson, 1992; Cattaneo et al., 
1990). The ring fixator allows transport of bone segments in any direction with the 
use of oblique pulling or transverse tensioned wires or half-pins (Aronson et al., 
1989a; Cattaneo et al., 1992; de Pablos et al., 1994; Paley, 1990b). The basic 
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principles of the Ilizarov method are the same for bone transport as for lengthening 
(de Pablos et al., 1994). However, the supplementation with autogenous bone graft 
after operative debridement of the ends of the bone can accelerates and facilitates 
healing (Ciemy and Zom, 1994; Green, 1994). Bone transport can also be used to 
treat congenital pseudarthrosis of the tibia, a condition that has remained refractory 
to most conventional methods ofbone-grafting (Fabry et aL, 1988; Paley et al., 1992) 
1.2.4. Reconstruction of the mandible 
Functional and aesthetic reconstruction of the mandible with bone loss 
continues to be a formidable problem. Grafts, flaps, and synthetic material have 
been used to reconstruct the mandible, each with unique shortcomings. Distraction 
osteogenesis is a form of in vivo tissue engineering that results in spontaneous 
generation of viable bone. McCarthy et al. (1992) were the first to report using 
distraction osteogenesis clinically for reconstruction of mandible. Since then, 
mandibular distraction osteogenesis has given the clinician an alternative method of 
treatment when conventional orthognathic surgery does not suffice. In severe 
maxillary or mandibular retrognathic patients, distraction osteogenesis reduces the 
risk of nerve damage and decreases the relapse potential of the surrounding soft 
tissue (Fisher et al., 1997; Sun et al., 1996; Day et al., 1997; Matano et al., 1994). 
The clinicians are able to advance the maxilla or mandible 20-30 mm or more by 
distraction osteogenesis to allow normal function of patient with congenital 
anomalies such as Nager's or Crouzon's syndrome (Costantino and Friedman, 1991; 
Chin and Toth, 1996; McCarthy et al., 1992; Glat et al., 1994). 
Distraction osteogenesis has been applied successfully to some of the most 
challenging conditions in orthopaedic surgery. The surgical and distraction 
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techniques have been developed well. Little has been addressed on the cellular and 
molecular aspects of distraction osteogenesis. In fracture healing, researchers have 
shown the biochemical events and the regulatory roles of different growth factors in 
the fracture callus. Using the animal model of the distraction osteogenesis and 
fracture healing, two processes can be compared to enhance our knowledge on the 
effect of tensile force on osseous tissue. 
1.3. Bone-specific Alkaline Phosphatase (BALP) 
Alkaline phosphatase (ALP) is the common name for a family of isozymes 
with similar catalytic properties that hydrolyze a large variety of phosphomonesters 
at a rather high pH value. The enzyme is widely distributed in nature and is found in 
large range of organisms from plant to vertebrates. 
In mammals, ALP consists of a group of true isozymes encoded for at least 
four different gene loci: The L/B/K locus determines the so-called liver/boney^idney 
of "tissue specific" ALP and is expressed in vitally all tissues. Besides, three other 
tissues specific ALP are the intestinal, placental, and germ cell ALP. For the tissue 
non-specific ALP isoforms, such as liver- and bone-specific ALP, difference arises 
from the post-translational modification of the same gene product. Thus, strictly 
speaking, they are considered as isoforms but not isozymes. The carbohydrate 
moieties of liver-specific ALP and bone-specific ALP depend on the way sialic acid 
and the 0-linked sugar chain linked to the molecules (Miura et al., 1994) 
Anderson (1989) suggested that the BALP had an important role in the 
skeletal mineralization. However, Robison (1923) was the first to recognize the role 
of ALP in skeletal mineralization. BALP appears as a tetrameric protein localized in 
the plasma membrane of the osteoblasts. High activity was observed in the bone 
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matrix vesicles, in the functionally active plasma membrane fragment of the 
osteoblast, and in the initial site of hydroxyapatite crystal formation. In the bone 
mineralization processes, BALP hydrolyses the organic phosphate esters resulting in 
local high inorganic pyrophosphate concentration, which facilitates the precipitation 
of calcium phosphate. BALP can also destroy the physiological crystal growth 
inhibitors such as inorganic phosphate and ATP through it hydrolase activity. In 
addition, it acts as an inorganic phosphate transporter and actively transports calcium 
ion through the ATPase activity (Whyte, 1994). Besides, the extracellular matrix 
binding domain of BALP may be important in directing the migration of matrix 
vesicles along the collagen fibers during the process ofbone mineralization. 
Since serum ALP activity is contributed not only by bone but also by liver 
origin, a raise in serum ALP level is not restricted to bone formation. Thus, the 
measurement of serum total ALP lacks the specificity and sensitivity for bone 
formation. Leung et al. (1993) had shown that BALP was a specific indicator for 
osteoblastic activity. Moreover, BALP is a more sensitive biochemical marker of 
bone activity and its level truly reflects the bone activity (Liu et al., 1996). The 
introduction of the wheat germ lectin precipitation assay by Rosalki and Foo (1984) 
provides an accurate, easy-to-perform and less expensive method for measuring 
serum BALP activity. The Department of Orthopaedic and Traumatology has 
adapted the method and use the auto-analyzer for routine assay of BALP activity to 
monitor the bone formation activity in the experiments (Leung et al., 1993). 
1.4. Osteocalcin 
Osteocalcin, also called bone Gla protein (BGP) and y-carboxyglutamate 
protein, is a vitamin K-dependent, calcium-binding protein of bone. It is the most 
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abundant noncollagenous bone peptide and the seventh most abundant protein of the 
human body. The protein contains three residues of a calcium binding y-
carboxyglutamic acid (Hauschka et al., 1975; Lian et al., 1982; Price et al., 1976a; 
Price et al., 1976b). In the presence of calcium, the Gla residues allow specific 
conformational changes and promote osteocalcin binding to hydroxyapatite and 
subsequent accumulation in bone matrix (Hauschka and Carr, 1982). Although the 
precise function of osteocalcin in bone has not been clarified, several of its properties 
are well defined. The de novo biosynthesis of osteocalcin is by osteoblasts. The 
expression of osteocalcin was depended on vitamin K and carbon dioxide and 
modulated by vitamin 1,25 (OH)2 D3. 
Although the majority of synthesized osteocalcin associates with bone, 
nanomolar concentrations circulate in the blood. Thus, it is possible to measure the 
serum concentration as a noninvasive index of bone turnover. Serum concentrations 
of osteocalcin reflect the portion of newly synthesized protein that is not bound to the 
mineralizing bone but released into the circulation (Price, 1985; Price and Nishimoto, 
1980). Several studies provide evidence that serum osteocalcin is derived form new 
cellular synthesis rather than from degradation of bone and is a marker for bone 
formation. Moreover, it frequently parallels alkaline phosphatase activity, the marker 
of osteoblast activity and bone formation mentioned above (Gerstenfeld et al., 1987; 
Lian et al., 1985; Cole et al., 1985; Gundberg et al., 1983; Price and Williamson, 
1981; Dannucci et al., 1987; Price, 1985). 
It has also suggested the changes in serum osteocalcin levels reflect the 
osteoblast activity. Analysis of rat bone before and after space flight demonstrated a 
40% decrease in semm and bone osteocalcin and a significant increase in bone 
fragility (Patterson-Buckendahl et al., 1985; Morey and Baylink, 1978). Moreover, 
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in growing rats, semm osteocalcin levels increase and reach a stable value when the 
rapid growth period has ceased. When bone osteocalcin reaches a constant value, 
serum osteocalcin also is constant (Patterson-Allen et al., 1982; Price and Willamson, 
1981). All the studies suggested that there is correlation between bone formation and 
concentration of serum osteocalcin. 
During either fracture healing and distraction osteogenesis, new osseous 
tissue is formed. Thus, according to pervious studies by others, the serum 
osteocalcin concentration should be increased during the active bone forming phase. 
1.5. Bone Growth Factors 
Bone growth factors are a group of proteins synthesized by bone cells and 
known to regulate the replication and differentiation function. Although the bone 
growth factors are synthesized by osteoblasts and other bone cells, these factors are 
not specific to the skeletal system. Systemic growth factors may be present in serum 
and are frequently synthesized by the liver or may be released after platelet 
aggregation.. The growth factors are able to incorporate into the extracellular matrix 
during bone formation, but small amounts can also be trapped systemically from 
serum and incorporated into the matrix. The paracrine effects of the bone growth 
factors are only in the local cellular environment, thereby stimulating neighboring 
bone cells to proliferate and increase matrix protein synthesis. In addition, the 
autocrine effects are that the cells, which produce the growth factors, can stimulate 
themselves to produce additional metabolic activity. These factors are stored in the 
bone matrix until remodeling or trauma causes their solubilization and release. After 
release, the proteins can regulate osteoblast and osteoclast metabolism during bone 
remodeling and may initiate and control a healing response after bone trauma. They 
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become the main regulators of bone-cell metabolism. Skeletal cells synthesize 
fibroblast growth factors (FGFs), transforming growth factors-P (TGF-P), bone 
morphogenetic proteins, and others. 
In this study, acidic fibroblast growth factor (aFGF), basic fibroblast growth 
factor (bFGF), and transforming growth factor-pi were chosen because their roles in 
the growth and differentiation of many tissues have been documented in many 
publications. For the skeletal system, FGFs and TGF-pl have both osteogenic and 
angiogenic properties. With a better understanding of the actions of the three growth 
factors on in vitro and in vivo bone formation, it is possible to elucidate the cellular 
effect of mechanical strain on osseous tissue in the distraction osteogenesis and 
fracture healing models. 
1.6. Fibroblast Growth Factors (FGFs) 
Fibroblast growth factors are a family of structurally related polypeptides 
(Burgess and Maciag, 1989; Baird, 1993). The family currently consists of nine 
proteins FGF-1 through FGF-9 (Abraham et al. 1986a; Jaye et al. 1986; Moore et al., 
1986; Delli Bovi et al., 1987; Taira et al.，1987; Zhan et al., 1988; Marics et al., 1989， 
Finch et al. 1989，Brookes et al. 1989, Tanaka et al., 1992; Iida et al., 1992; 
Miyamoto et al., 1993). FGF-1 and FGF-2, known as acidic FGF and basic FGF, 
were the first of these proteins to be found and studied most extensively. Acidic FGF 
and basic FGF are approximately 50% homologous at the amino acid level. 
However, the two proteins do not have a hydrophobic leader sequence (Abraham et 
al., 1986b; Jaye et al., 1986). Proteins must have a leader sequence for the cell to 
secret. Thus, the mechanism by which these factors are secreted by cells is not clear. 
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The FGFs may be released from cells following cell damage or death. (Gajdusek and 
Carbon, 1989; McNeil et al., 1989). Others suggested that FGFs may first complex 
with another factor such as proteoglycan and then exit the cells (Hill et al., 1992). 
This may be a possible mechanism since aFGF and bFGF readily bind to heparin 
sulfate proteoglycans (Saksela et al., 1988). The FGFs exhibit potent mitogenic 
activity for cells of mesodermal and neuroectodermal origin (Spom and Roberts, 
1990). In skeletal tissue, FGFs mainly have a proliferative effect on osteoblasts and 
less effect on protein synthesis. 
1.6.1. Acidic Fibroblast Growth Factor (aFGF) 
aFGF is an 18-kDa protein with 140 amino acids (Gimenez-Gallego et al., 
1985) It has been shown to localize in the nucleus of some cells (Sano et al., 1990; 
Speir et al., 1991) and was initially isolated from the central nervous system and is 
now known to be synthesized by a variety of tissues (Esch et al., 1985a). In wound 
healing, topical application of aFGF caused a significant acceleration of dermal 
wound closure in mice (Thomas, 1987). The presence of aFGF in osteoblast-
enriched cells from fetal rat calvaria culture stimulated DNA synthesis to the same 
extent in osteoblasts as well as in non-osteoblastic cells (Rodan et al., 1987). The 
stimulatory effect of aFGF could be enhanced by complexing with heparin 
(McCarthy et al., 1992). aFGF also sustained the growth of these calvaria cells in 
low concentrations of serum for up to 72 days. However, the cells lost their 
osteoblastic features gradually. 
To study bone formation in culture, rat calvaria were incubated either with 
[^H]thymidine or [^H]proline as indices for cell proliferation and collagen synthesis, 
respectively. aFGF exhibited a stimulation of collagen synthesis in calvaria. During 
fracture healing in rats, aFGF has been shown to stimulate callus formation (Jingushi 
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et al.，1990). The high concentration of aFGF in bone suggests that aFGF is an 
important factor in regulating fracture healing or bone remodeling (Hauschka et al., 
1986). aFGF in the presence of heparin demonstrated a stimulatory effect on bone 
resorption in cultured mouse calvariae (Tashjian and Levine, 1978; Simmons and 
Raisz, 1991). In a system similar to that of Simmons and Raisz, the stimulatory 
effect of aFGF was shown to associate with osteoclastosis and was inhibited by 
calcitonin (Shen et al., 1989). 
1.6.2. Basic Fibroblast Growth Factor (bFGF) 
Compared to aFGF, bFGF from the same family of growth factors is more 
widely studied. bFGF was initially purified from extracts of bovine pituitary glands 
and later in bovine brains (Gospodarowicz et al., 1974，1978). Three isoforms of the 
protein (18 kDa, 21 kDa, and 22.5 kDa) are found in the cytoplasm or nucleus of 
neurons and glia (Gonzalez et al., 1995). bFGF is a highly conserved and widely 
distributed protein. For example, human and bovine bFGF differ only in two out of 
155 amino acids (Abraham et al., 1986b). bFGF has been implicated in the 
proliferation and differentiation of a wide variety of cells (Thomas, 1987; Rifkin and 
Moscatelli, 1989; Gospodarowicz et al., 1986). One of the best-known effects of 
bFGF is its ability to induce angiogenesis (Thomas et al., 1987; Esch et al., 1985b). 
Like aFGF, bFGF has similar effect on bone cell function but appears to be more 
potent than aFGF as a bone cell mitogen (Canalis et al., 1987, 1988; McCarthy et al., 
1989). 
In the development of limbs in embryogenesis, bFGF is expressed by 
proliferating chondrocytes and localized to the perichondrium (Gonzalez et al., 
1990). bFGF expression is spatially and temporally organized in the epiphyseal 
growth plate as differentiation proceeds, so that it is present in the resting and 
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proliferation chondrocytes (Jingushi et al, 1995). These observations suggest a 
mitogenic role for bFGF in mesenchymal proliferation and a possible morphogenic 
role during cartilage formation. 
Several studies have used bFGF for in vivo stimulation of bone formation 
and bone-healing. bFGF has been incorporated into demineralized bone matrix and 
implanted intramuscularly in rats. Aspenberg et al. (1989) showed that FGF-loaded 
bone matrix exhibited increased new bone formation. Fracture healing in rats has 
been stimulated by 50mg bolus doses ofbFGF and caused increased callus formation 
and bone mineral content (Kawagushi et al., 1993). Moreover, systemic 
administration of bFGF to rats caused increased osteoblast proliferation and 
endosteal bone formation (Mayahara et al., 1993). 
In addition to the stimulatory effect on osteoblast, bFGF is also a potent 
angiogenic factor found in most normal tissues (Vlodavsky et al., 1987; Folkman et 
al., 1988). The application of bFGF lead to angiogenesis in chick embryo 
chorioallantoic membrane and comea (Folkman and Klagsbrun, 1987). The 
angiogenic activities of bFGF are implicated in the vascularization of scar tissue that 
occurs during wound healing of all tissues. In the study of brain injured (Logan et 
al., 1992; 1994)，bFGF was shown to act in a paracrine and/or autocrine fashion 
initiating new capillary growth that occurs in damaged neural tissue. According to 
these studies and others, bFGF has been established as an angiogenic factor. 
In fracture healing, FGFs have been shown to be present in the fracture 
callus (Bolander, 1992). It was suggested that FGFs play a role in the regeneration of 
the bony tissue in fracture healing. Hence, similar to fracture healing, distraction 
osteogenesis also involves the massive regeneration of new osseous tissue. The 
various actions of the FGFs may play a role in distraction osteogenesis. In this study, 
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the localization of the FGFs in the distracted new tissue will be depicted. This 
information may help us to understand more about the effects of the mechanical 
strain on the expression of FGFs, which affects the different cell activities in the 
distraction callus of distraction osteogenesis. 
1.7. Transforming Growth Factor-pi (TGF-pi) 
Transforming growth factor-p is a member of a recently discovered 
superfamily of polypeptides that seem to regulate cellular activity in organisms from 
Drosophila to human. This multifunctional cytokine is involved in the regulation of 
growth and differentiation ofmany cell types and in general, TGF_P has a stimulative 
effect on cells of mesenchymal origin and an inhibitory effect on cells of ectodermal 
origin. Five subtypes ofTGF_p have been found and named TGF-pl to TGF-p5. 
Almost all the cell types have TGF-p receptors (Derynck et al., 1988; Jakowlew et 
al., 1988;Rosa et al., 1988). 
TGF-pi is a 25-kDa dimer composed of two identical disulfide-linked 
chains. The mature 112 amino acid monomers are derived from the carboxy-terminal 
portion of a 290 amino acid precursor (Derynck et al., 1985). The amino sequence of 
both TGF"P1 and TGF-p2 is highly conserved among mammalian species, and a 
remarkably high degree of sequence homology occurs between the precursor parts of 
the molecules. Bone and platelets contain almost 100 times more TGF-p than any 
other tissue, and osteoblasts bear the highest amount of TGF-p receptors (Spom and 
Roberts, 1990; Robey et al., 1987). TGF-pi has become the prototype of its large 
family. Through the studies of TGF-pi, we may have better understanding of the 
action of the protein in different cell types especially those related to skeletal tissues. 
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TGF-P is an osteoblast stimulant. In isolated osteoblasts, TGF-P has 
different effects on different models of the osteoblast phenotype. With some cell 
targets, it stimulates proliferation and inhibits differentiation function (Centrella et 
al.，1987; Globus et al., 1988; Wrana et al., 1988). In the in vitro studies, TGF-P 
inhibits proliferation and stimulates differentiated function fNoda and Rodan, 1986; 
Pfeilschifter et al., 1987a，1987b). The initial in vivo studies demonstrating 
stimulatory effects of TGF-P on bone formation used injections of TGF-p into rat 
and mice calvaria and revealed a marked increase in bone formation (Joyce et al., 
1990a,c; Noda and Camilliere, 1989). In addition, TGF-p in a methylcellulose gel 
carrier was able to stimulate bone-healing in a calvarial defect model in rabbits (Beck 
et al., 1991). Systemic administration in rats and rabbits causes endosteal bone 
formation and generalized osteoblast hypertrophy with high matrix protein synthesis 
activity (Terrell et al., 1993). When TGF-p was applied continuously to a healing 
osteotomy in rabbits, it resulted in increased callus formation and increased maximal 
bending strength of the osteotomy (Lind et al., 1993). TGF-p stimulates chondrocyte 
proliferation and matrix synthesis (Bolander, 1992; Joyce et al., 1990b). The 
expression of TGF-P in bone and cartilage cells such as cells in fracture callus and 
growth plate chondrocytes (Gelb et al., 1990; Thorp et al., 1992) suggests an 
autocrine or paracrine role of the TGF-p in osteogenesis and chondrogenesis. 
Although the roles of TGF-P in the skeletal tissue have been well 
documented in many publications, little is known about its role in the process of 
distraction osteogenesis. Massive synthesis of extracellular matrix and recruitment 
of different cell types to the distraction site take place during the distraction. It is 
postulated that TGF-P may play a role in distraction osteogenesis for the 
differentiation and proliferation of mesenchymal cells during the distraction. 
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Moreover, when its expression in distraction osteogenesis is compared with that in 
fracture healing, the possible effect or mechanism of tensile force on the expression 
ofTGF-p can be elucidated. 
1.8. Fracture Healing 
1.8.1. Histology 
Histologically, progression of fracture healing can be divided into four 
distinct stages. Each stage has been well described in literatures (Bolander, 1992; 
Joyce et al, 1990c). They are (1) immediate injury response and hematoma; (2) 
initial intramembranous bone formation response; (3) chondrogenesis; (4) 
endochondral ossification. The involvement of many local and systemic regulatory 
factors such bone derived growth factors, hormones, cytokines and extracellular 
matrix components has been documented in many publications (Simmons, 1985; 
Triffitt, 1987; Canalis et al., 1988a; Noda and Camilliere, 1989; Celeste et al., 1990; 
Jingushi et al, 1990; Joyce et al, 1990a，b). 
1.8.2. Growth Factor Expression 
Growth factors as the local mediator in the healing process have been 
extensively studied. Among these factors, TGF-pl has been shown to be involved in 
the early stage of fracture (Bolander, 1992). During the inflammatory response, the 
platelets at the hematoma site release significant concentration of TGF-pl. TGF-pl 
is bound to the periosteal cells. In the later stages, TGF-pi is found in chondrocytes 
and hypertrophic chondrocytes of the callus. TGF-p 1 may have a role in regulating 
cartilage matrix calcification and endochondral ossification. The presence ofTGF-pl 
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at the early stages of fracture repair suggests that it may initiate proliferation of the 
callus formation and regulate the process. 
From Bolander's study (1992), aFGF found to be expressed at low levels 
but increased expression during the chondrogenesis stage. Supported by others 
(Jingushi, 1990)，this may imply that aFGF has a role in the formation of cartilage. 
Although expression of bFGF in fracture healing is at constant levels, many 
published reports have suggested that bFGF plays significant roles in bone healing 
(Bourgue, et al, 1993; Kawagushi et al, 1993; Nagai et al, 1995; Wang et al., 1996; 
Wang and Aspenberg, 1994). 
The regulatory mechanism of the growth factors in fracture repair shed light 
into the even-faster bone forming process of distraction osteogenesis. Both healing 
processes have similarities and differences in every aspect. The comparison of the 
two may demonstrate the effect of the largest difference, which is the continuous 
tensile force application at the fracture site during the distraction period. 
1.9. Distraction Osteogenesis 
1.9.1. Histology 
Distraction osteogenesis can be divided into three different stages. In each 
stage, the histological features are distinct (Aronson et al. 1989b, 1990; Ilizarov, 
1990，1992). 
Latency Stage 
In general, the fracture is rested for a period of seven to ten days. During 
this period, the histologic features at the osteotomy site are very similar to the 
immediate injury responses of fracture repair. Hematoma is formed at the osteotomy 
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site accompanied by inflammatory responses. Inflammatory cells invade the newly 
formed tissue around the osteotomy site. The undifferentiated cells around the cortex 
and from the periosteum proliferate. 
Distraction Stage 
Intramembranous ossification takes place around the cortex. The periosteal 
cells differentiate into osteoblasts and condense to form bone at the sub-periosteal 
region. As the gap of the osteotomy site is expanded, the woven bone formed around 
the cortexes is also expanded in width and length. The woven bone is growing 
towards the center of the distracting callus. Meanwhile, at the middle of the 
distracting callus, the fibrous interzone is proliferating. Thus, the radiodense and 
radiolucent zones are observed in the radiography of the distraction site. 
Microcolumn of the trabecular bone and the collagen are aligned with the direction 
of the distraction force. 
Consolidation Stage 
After the distraction has stopped, the fibrous intrezone is still observed. 
However, it is diminished as the trabecular bone at the distracted callus advances 
closer toward the center. The trabecular bone formed during the distraction becomes 
mature. The remodeling of the distracted callus were taken place during the 
consolidation period. 
1.9.2. Growth Factor Expression 
The expression of the growth factors in distraction osteogenesis has not 
been well established. In this study, the expression of different growth factors is 
examined by immunohistochemistry, which uses antibodies to the growth factor to 
reveal their location in the distracted callus. 
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1.10. Aim ofthe Study 
The regeneration potential of the skeletal tissue is manifested in the process 
of fracture repair and distraction osteogenesis. The difference between these two 
processes lies in the application of tensile force on the fracture callus. Although 
many studies have been on different biochemical events in fracture healing. Little is 
known in distraction osteogenesis. Moreover, the mechanism of osteogenesis under 
a tensile force remains unclear. By establishing animal model of fracture healing and 
distraction osteogenesis, we can compare the biochemical events in both processes. 
In tum, we aim to enhance our understanding of the cellular and molecular effects of 
the tensile force on the skeletal tissue. 
In this study, distraction osteogenesis and fracture healing models were first 
established. Mineralization and bone formation markers were monitored weekly in 
both regeneration processes. Finally, in situ protein expression pattem of the growth 
factors was investigated and correlated with the cellular events. Compared to 
fracture healing, the difference in biochemical events during the distraction period of 







2.1. Animal Model 
2.1.1. Source of Animal 
The animals used in the study were purchased from the slaughterhouse that 
supplies the livestock to Hong Kong market. An official removal permit was 
obtained from the Agriculture and Fishery Department, Hong Kong. The procedures 
of transferring live goats from the slaughterhouse to the University Laboratory 
Animal Service Center were under the supervision of the Agriculture and Fishery 
Department. 
2.1.2. Animal Operation 
Forty-seven Chinese goats weighting in average of27.1kg i3.3kg were used 
in the study. The operation was carried out under general anesthesia and aseptic 
technique. With the aid of a plastic template, two parallel transosseous holes were 
drilled on the proximal end of the left tibia by a 2.7mm diameter drill bit (Figure 
2.1A). A pair of3.4 mm Stainnman pins was inserted into the holes. Each pair of the 
pin was parallel to each other. Another pair was transosseously inserted into the 
distal end similarly. Then a sub-periosteal osteotomy was performed at the mid-shaft 
of the tibia by an air-driven oscillating saw (Figure 2.1B). After sutured the wound 
of the osteotomy site (Figure 2.1C), the Stainnman pins were interlocked onto the 
self-designed external distraction fixator (Figure 2.1D). The external distraction 
fixator was fabricated in the mechanical workshop of the Chinese University of 
Hong Kong. It was made of stainless steel and strengthened aluminum (Figure 2.2) 
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and has a semicircle configuration. Unlike the Ilizarov fixator, the pins of the 
present fixator are parallel to each. The design enabled manual distraction of the 
proximal pins from the distal pins in a controlled fashion by two threaded telescoping 
support rods connecting the two ends. Each 360° tum of the knot on the telescoping 
support rods was equal to one-millimeter distraction. After the operation, the goats 
were randomly divided into distraction osteogenesis group and fracture healing 
group for the following treatment described. The animals were resided in the 
Laboratory Animal Service Center, CUHK until the date of sacrifice. The animals 
were taken care by the service center technicians and supervised by the director of 
the service center. All the operation procedures and the subsequent distraction 
procedure were approved by the University Ethic Committee. 
2.1.3. Fracture Healing Model 
25 osteotomized goats were randomly selected to the fracture healing group. 
This group of animals did not receive any distraction. They were kept in the goat 
pans to let the fracture heal naturally. 
Standardized x-ray radiography of the osteotomized tibia with aluminum 
step wedge in both anteroposterior and lateral projections was taken weekly after the 
operation. The radiography was used to follow up the progress of the fracture 
healing until the animals were euthanized. The anteroposterior projection of the 
radiography was also used for measuring the bone mineral density of the calluses 
which was described in the Section 2.3. 
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2.1.4. Distraction Osteogenesis Model 
After the operation, 22 goats were randomly chosen as the distraction 
osteogenesis group. They rested for the latency of 7 days. Then the distraction 
started at a rate of 1mm per day, 6 days per week. The longest period of distraction 
was lasted for four weeks (i.e. 24mm distraction). 
Standardized x-ray radiography of the osteotomized tibia was taken as 
follow-up for the progress of the distraction and it was the same as that of the 
fracture healing group. 
2.2. Sample Collection 
All the animals in distraction osteogenesis and fracture healing group were 
randomly divided into 6 sub-groups. For the distraction osteogenesis group, one sub-
group was euthanized at the last day of the latency period of distraction osteogenesis 
(Week 1). Three other sub-groups were during the distraction period at Week 2，3， 
and 5 post-osteotomy. During the consolidation period, two sub-groups were 
assigned as Week 8 and 12 post-osteotomy. For the fracture healing group, the sub-
groups were assigned as the same time points post-osteotomy of the distraction 
osteogenesis group, so that comparison of the two groups could be made in different 
experiments. 
2.2.1. Tissue Sample Collection and Preparation 
Both groups of goats were euthanized by over-dosage of pentobarbital 
before the tissue at the osteotomy site was removed from the animal. All the 
distracted calluses and the fracture calluses were removed under aseptic conditions 
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and the tissue was rinsed in sterile phosphate-buffered saline. Then the calluses were 
fixed in 0.9% buffered formalin for two days and decalcified in 9% formic 
acid/formalin solution (Merck, Cat#100264 & 104003, respectively). The solution 
was changed weekly until the calluses were completely decalcified and softened. In 
general, the length of decalcification was around seven weeks. The completeness of 
the decalcification was checked by saturated ammonium oxalate solution. The 
samples, then, were dehydrated in up-graded alcohol and two changes of xylene. 
The specimens were embedded in paraffin wax and 7^im sections were obtained for 
the H&E staining and the immunohistochemistry of various growth factors used in 
the study. 
2.2.1.1. Test for the Complete Decalcification of the Calluses 
After six weeks of decalcification, 5ml old decalcification solution of the 
sample was taken. Concentrate ammonium solution (Merck, Cat#105426) was 
added until the solution changed to basic from acidic. If the alkalized solution tumed 
milky and fine white precipitate was observed, 5ml saturated ammonium oxalate 
solution (Merck, Cat#101192) was added and waited for 30min. If the final solution 
tumed clear, the decalcification was needed to extend one more week to ensure a 
complete removal of calcium from the tissue. Once the alkalized solution was not 
clear, the decalcification was continued with new decalcification solution. 
2.2.2. Blood Sample Collection and Storage 
During the processes of the distraction osteogenesis and fracture healing, 
lOmL blood samples were taken for the measurement of the serum bone-specific 
alkaline phosphatase activity and the concentration of serum osteocalcin. Blood was 
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drawn at the day of operation, the third day and fifth day post-operation and weekly 
after the operation until the animals were euthanized. The serum was stored at -
80°C until the date of the assays for the bone-specific alkaline phosphatase activity 
and the concentration of osteocalcin. 
2.3. Bone Mineral Density Measurement of the Distracted 
Callus and the Fracture Callus 
Radiography of individual goat in distraction osteogenesis and fracture 
healing group was taken weekly with a standard aluminum step wedge (Figure 2.3). 
This step wedge acted as a calibrator for the bone mineral density measurement in 
this setup. The radiography was digitized and captured by the DiagnostiX 2048 
system (PACE SYSTEMS，GMBH). 
2.3.1. Fracture Healing Group 
The pixel density of the area along the fracture gap was measured by the 
image analyzer. The values were then calibrated with the pixel density of the 
aluminum step wedge image on the same x-ray film. A linear standard curve could 
be generated from a range of steps that was inclusive to the pixel density values 
measured at the desired zone. By plotting the pixel density against the thickness of 
the step wedge, a linear regression line was given with a general format as follow 
where x was the thickness of the aluminum step wedge and y was the pixel density. 
y = mx + c 
By substituting the pixel density of the desired zone (ymeasured) to the 
equation, the mineral density ofthat zone (Xmeasured) was found and it is in term ofthe 
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thickness of the aluminum step wedge. If the bone mineral density of the area was 
high, the corresponding thickness of the aluminum step wedge was thicker 
2.3.2. Distraction Osteogenesis Group 
In distraction osteogenesis, the distracted callus on the x-ray was equally 
divided into 3 different zones. The three zones were defined as the proximal, middle, 
and distal part of the callus (Figure 2.4). The proximal zone was an area of the callus 
near to the proximal tibia. The distal zone was an area of the callus near the distal 
end of tibia. The middle zone was the area between the proximal and distal zone. 
The pixel density of each zone was measured by the same method used for the 
fracture healing measurement described in Section 2.3.1. 
2.4. Serum Bone Specific Alkaline Phosphatase (BALP) Activity 
The method to measure the serum BALP activity was based on the wheat 
gerai lectin specific binding ofthe BALP. This assay was first described by Rosalki 
and Foo (1984, 1986). We department had adopted the method and used the 
ABBOTT VP system auto-analyzer (Abbott Laboratory Ltd.) to carry out the assay 
(Leung et al.，1993). Since BALP was precipitated out by the wheat germ lectin, the 
BALP activity was measured by subtracting the non-bone alkaline phosphatase 
activity from total serum alkaline phosphatase activity. 
2.4.1. Wheat Germ Lectin (WGL) Precipitation ofBALP 
2.4.1.1. Reagents 
Triton X-100 Solution 
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4.0 g of Triton X-100 (Sigma, Cat#X100) was dissolved into 100mL of 
distilled water. The solution was mixed well and stored at room temperature. 
WGL/Triton X-100 Mixture 
Wheat germ lectin (from Triticum Vularis) was bought from Sigma (Cat# 
L9640). 0.5% WGL in 4% Triton X-100 mixture was made by dissolving 0.01g 
WGL into 2mL 4% Triton X-100. 
Agent® Alkaline Phosphatase Reagent (ABBOTTS 
The reagent has two different packages. One could be reconstituted to 21mL 
of substrate solution; the other 12 mL of solution. 33mL of substrate solution could 
be used for 30 samples measurement. Adjusted the volume of the substrate 
according to the number of samples being measured. 
2.4.1.2. Preparation and Measurement of Samples 
Thawed the required serum samples at room temperature. For each sample, 
non-bone ALP was made by 50^iL serum plus 50^iL WGL solution. Total ALP was 
made by 50^iL serum mixed with 50^L 4% Triton X-100. Blank sample was 
prepared by replacing serum sample with equal volume of MQ water. Incubated all 
the mixtures at 37°C for 30 minutes. Span down all the samples at 12000g for 10 
minutes and kept the samples at room temperature. Transferred the supernatant of 
non-bone ALP and total ALP into the sample cups of the VP auto-analyzer. Set up 
the auto-analyzer as described in the following Section 2.4.1.3 and measured the 
absorbency at OD415. The printout was the ALP activity that had been 
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automatically calculated by the auto-analyzer. The BALP activity was the difference 
between total ALP activity and non-bone ALP activity. 
2.4.1.3. Auto-analyzer Setup 
Added enough degassed water into the incubation trough. Placed the 
circular multicuvette into the trough. Checked the optical filter for 415nm. Used the 
"Wash" program to wash the substrate delivery tubing by MQ water. Then replaced 
the MQ water with ALP substrate (A-gent®, ABBOTT) and Primed the tubing by 
entering “00” and “2’’. Selected the Test Mode "18" for ALP assay to start the 
measurement. The auto-analyzer specification for ALP assay was as follow: 
Filters 450/415 
Syringe Ratio 1:101 
Analysis Time 5 minutes 
Carousel Revolutions 3 
Incubation Temperature 37°C 
End-point or Rate RATE 
Reaction Direction Down 
Calibration Factor 10100/Filter Factor 
Zero-adjustment 1800 
2.5. Quantification of the Osteocalcin in Serum 
In addition to the measurement of the serum bone-specific alkaline 
phosphatase activity, the blood samples were also used to measure the serum 
concentration of osteocalcin. "NovoCalcin" ELISA kit (MatraBiosystemes, USA, 
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Cat#8002) was used to measure the amount of intact {de novo) osteocalcin in serum. 
Although the kit was intended to measure human osteocalcin, the manufacturer had 
provided information to show that the antibody in the kit was capable to cross-react 
with goat osteocalcin. The anti-osteocalcin antibody was raised to against bovine 
osteocalcin. 
2.5.1. Reagent and Sample Preparation 
All the reagents stated in the procedures were provided in the kit unless 
there was specification. Before the beginning of the assay, the kit must reach to 
room temperature. Prepared 500mL of IX Wash Buffer by diluting the 10X Wash 
Buffer with MQ water. Diluted the samples 20 times with IX Wash Buffer. 
Reconstituted the Standards and the Controls with 0.5mL of IX Wash Buffer. 
2.5.2. Detection Procedures 
Added 25jaL of sample, NovoCalcin Standards or Controls to each well of 
the Osteocalcin Coated strips. Then added 125^L of anti-osteocalcin antibody to 
each well and incubated for 2 hours (±10 minutes) at room temperature (20-25°C). 
During the incubation, reconstituted Enzyme Conjugate with lOmL of IX Wash 
Buffer. 
After the two-hour incubation, manually inverted strips to empty all the 
content in the wells. Added 300^L of IX Wash Buffer to each well and manually 
inverted strips. Repeated two more times for a total of three washes. Vigorously 
blotted the strips dry on paper towels after the last wash. Added 150^L of the 
reconstituted Enzyme Conjugate to each well. Incubated for 60 minutes (±5 
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minutes) at room temperature (20-25°C). Prepared the substrate solution by putting 
the Substrate Tablet into each required bottle of Substrate Buffer. 
After the Enzyme Conjugate Incubation, manually inverted strips to empty 
the content. Added 300^iL of IX Wash Buffer to each well and manually inverted 
strips to empty the wash buffer. Repeated two more times for a total ofthree washes. 
Vigorously blotted the strips dry on paper towels after the last wash. Added lSO^L 
of Working Substrate Solution to each well. Incubated for 35 minutes at room 
temperature (20-25°C). To stop the reaction, added 50^iL ofNaOH provided in the 
kit to each well. Read the optical density (OD) at 405nm within 15 minutes of 
NaOH addition. Universal Microplate reader ELX 800UV from Bio-Tek 
Instruments, Inc., USA was used to read the microplate. The "KC4 Microplate 
Reader" program come with the microplate reader could automatically calculate the 
calibration curve and converted the sample's OD to concentration. The 4-parameter 
calibration curve equation were shown below: 
y = ( A - D ) / ( l + ( x / C f ) +D 
2.6. Localization of the Growth Factors in Distraction 
Osteogenesis and Fracture Healing 
Immunohistochemistry was employed to localize the three different growth 
factors on the sections of the distraction osteogenesis and fracture healing. The 
expression patterns of basic fibroblast growth factor, acidic fibroblast growth factor, 
and transforming growth factor-pl were investigated. Since the primary antibodies 
to these growth factors were against bovine or human antigens, the cross-reactivity of 
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individual antibody with the corresponding goat antigens was checked with various 
methods. For example, dot blotting and Westem Blotting were used. 
2.6.1. Immunohistochemistry of the Growth Factors 
2.6.1.1. Reagents and Solution Preparation 
PhosDhate Buffered Saline (PBS) 
Dissolved 1.44g Na2HPO4 (Sigma, Cat#S0876), 0.24g K H 2 P O 4 (Sigma, 
Cat#P5379), 8.0g sodium chloride (Merck, Cat#106404), and 0.2g KC1 (Merck, 
Cat#104936) in 900ml distilled water. Adjusted pH to 7.4 and made the final 
volume of 1000ml with distilled water. 
Bovine Serum Albumin - Phosphate Buffered Saline (PBS-BSA) 
Dissolved 0.4g of bovine serum albumin (Sigma, Cat#A7888) in PBS. 
Stirred for at least 10 minutes to ensure the albumin dissolved completely. All the 
primary and secondary antibody were diluted by PBS-BSA at different dilution 
factor specified below. 
Primary Antibody to: (Dilutent: blocking solution) 
TGF-betal (R&D Systems, Cat#AB-101-NA) (Dilution: 1:500) 
bFGF (R&D Systems, Cat#AB-33-NA) (Dilution: 1:400) 
aFGF (R&D Systems, Cat#AB-32-NA).(Dilution: 1:400) 
Biotinvlated Secondrav Antibody to: (Dilutet: Blocking solution) 
Rabbit IgG (DAKO, Cat#K0492) 




Diluted the normal serum with PBS-BSA solution in a 1:20 ratio. The 
normal semm used was depended on the species from which the secondary antibody 
was raised. For example, the secondary antibody in the DAKO 
StreptABComplex/HRP Duet, Mouse/Rabbit kit (Cat. No. K0492) was raised from 
goat, so the normal serum should be goat normal serum. 
3% Hydrogen Peroxide Solution 
Diluted 17.2ml 35% hydrogen peroxide (R&H, Cat#18304) with distilled 
water to make the final volume of 200ml of 3% hydrogen peroxide solution. 
Trypsin Solution 
Diluted the 0.25% trypsin solution (Gibco，Cat#25200-056) with PBS to the 
final concentration of 0.025%. Each slide required approximately 500fil of solution 
for the enzyme digestion. 
Hvaluronidase Solution (5mg/ml) 
Dissolved 35mg of hyaluronidase (Sigma, Cat#H3506) in 7ml PBS. Each 
slide required approximately 500^1 of solution for the enzyme digestion 
Citrate Buffer 
Solution A: 





Dissolved 14.705g citric acid (Trisodium dihydrate) (Merck, Cat#112005) 
in 500ml distilled water. 
Solution C: 
Mixed one part of solution A (lOOml) and four parts of solution B (400ml). 
Final 0.01M citrate buffer. pH 6.0 
Diluted 50ml of solution C with 450ml distilled water and adjusted the pH 
to 6.0. This final solution should be mixed before the commencement of each 
experiment. 
Detection Svstem 
StreptABComplex/HRP Duet, Mouse/Rabbit Kit (DAKO, Cat#K0492) was 
used for color development. The kit came with a stock solution of secondary 
antibody against mouse/rabbit that was useful in our experiment to detect antibodies 
against bFGF and aFGF. 
Diaminobenzidein (DAB) Solution 
A DAB tablet (Sigma, Cat#D5905) was dissolved in 10ml of PBS with 
lOO i^L of 0.3% hydrogen peroxide. 
Ammonia Water 




2.6.1.2. Experimental Procedure 
Goat growth plate and brain sections were used as positive controls for each 
antibody requested. Negative controls were run, omitting the primary antibody, in 
each case to assess the level ofbackground staining. 
Deparaffined the sections in two changes of xylene for 5 minutes. 
Rehydrated the sections with downgraded alcohol. Being washed in distilled water 
for 3 minutes, the sections were soaked in 3% hydrogen peroxide solution for 10 
minutes to quench all the endogenous hydrogen peroxidase activity. Rinsed in PBS 
for 5 minutes, the sections were placed in a humidified tray and digested with trypsin 
solution at 37°C for 5 minutes. Preheated the hyaluronidase solution at 3TC. 
Poured off the trypsin solution, one slide at a time. In a humid tray, the sections 
were digested with hyaluronidase at 37°C for 10 minutes. To further retrieve antigen 
on the tissue sections, the samples were microwaved (600W) in citrate buffer for 90 
seconds at high power. The solution should not be quite boiled. Cooled down 
slowly to room temperature. Blocked the samples with normal serum diluted 20 
times in PBS-BSA for 20 minutes at room temperature. Removed the blocking 
solution without washing PBS. Applied the correctly diluted primary antibody on 
the samples. For the negative control, used PBS-BSA solution to replace the primary 
antibody solution. Incubated at 4 � C ovemight. 
After the incubation of the primary antibody, the samples were wash in PBS 
for 5 minutes three times. Applied the secondary antibody that was depended upon 
the host of the primary antibody and incubated at room temperature for 30 minutes. 
Removing the secondary antibody by washing in PBS for 5 minutes, applied the 
streptavidin-biotin-horseradish peroxidase complex solution for another 30 minutes 
at room temperature. After adding the amplification system, diaminobenzidine 
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(DAB) was used as chromogen for color development. Within 5 to 10 minutes, the 
signal was appeared. Counterstained the sections with Mayer's Haematoxylin for 90 
seconds. Washed the sections with distilled water until no color was coming out 
from the tissues. Immersed into ammonium water for 5 seconds and washed with 
distilled water for 3 minutes. Dehydrated the sections by up-graded alcohol and two 
changes of xylene. Coversliped the sections with DPX mounting fluid (Fluka, 
Cat#44581). 
2.6.1.3. Evaluation of Immunohistochmical Staining Results 
Slides were examined using a Leica DMRB microscope, and a halogen 
lamp light source. Photomicrographs were taken with a Leica DM LD camera with 
Leica DM LD exposure control unit. Kodak Ektachrome 100 films were used for 
color photomicrographs. Immunostained slides were evaluated in a blinded fashion 
by three individuals, independently. The intensity of positive immunostaining was 
graded as +++，++，+，- for strong, moderate, weak, and negative, respectively. A 
grade of +/- was used to represent a focal or questionable weakly positive cell in the 
tissue sections. 
2.6.2. Verification of the Primary Antibody Used in the Study 
2.6.2.1. Tissue Preparation 
Goat brain was used as positive control because the primary antigen for 
raising the antibody against aFGF and bFGF was bovine brain. The growth plate 
were used for the presence of the three growth factors in the growth plate had been 
reported in the literature. The goat brain and growth plate were taken form the 
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animals. The tissues were undergone general tissue processes for histology and 
immunohistochemistry. 7|im sections were then made for the immunohistochemistry 
described in pervious Section 2.6.1. 
For dot blot and Western blotting, the brain tissue was deep-freezed by 
liquid nitrogen and crashed to very small pieces for homogenization. The small 
pieces oftissue was put into Tissue Extract buffer (50mM Tris-HCl, pH8.0; 200mM 
NaCl; lmM EDTA; lmM phenylmethylsulfonyl flouride; 0.05% Triton X-100) in a 
50% w/v fashion to extract the growth factors ovemight. Centrifuged down the large 
particles at 3000 rpm for 10 minutes. The supernatant as crude brain protein extract 
was then applied on dot blot and SDS-PAGE for Westem blotting. 
2.6.2.2. Antibody to Acidic Fibroblast Growth Factor (aFGF) 
2.6.2.2.1. Immunohistochemistry of Goat Brain and Growth Plate 
The same immunohistochemistry procedures described in Section 2.6.1 
were followed. The primary antibody to aFGF was applied on the brain and growth 
plate sections. The results were then compared with the published literatures. 
2.6.2.2.2. Dot Blot 
2.6.2.2.2.1. Materials and Reagents 
Dot blot apparatus 
It was bought from Bio-Rad Laboratories (Cat#170-6545). 
1X Tris Buffer Saline OX TBS) 
Dissolved 1.21g TRIZMA® BASE (Sigma, Cat#T1503), 9g sodium 
chloride (Sigma, Cat#S9888), 0.2g sodium azide (Sigma, Cat#S2002) in 800mL 
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distilled deionized water. Adjusted to pH 7.0 with HC1. Adjusted the final volume to 
lL with distilled deionized water. 
Tween 20 Wash Solution (lX TTBS) 
0.05% Tween 20 Wash Solution was made by adding 2.5mL of 20% Tween 
20 (Sigma, Cat#P7949) solution to 997.5mL ofTBS. 
Blocking Solution 
Added 5g skimmed milk powder to 500mL TBS. Stirred for 30 minutes to 
completely dissolve. 
Primary Antibody (Dilutent: 1% blocking solution) 
aFGF (R&D Systems, Cat#AB-32-NA).(Dilution: 1:400) 
Secondary Antibody (Dilutent: 1% blocking solution) 
Mouse/Rabbit IgG-biotin conjuaged (DAKO, Cat#K0492) 
Detection Svstem 
StreptABComplexyHRP Duet, Mouse/Rabbit Kit (DAKO, Cat#K0492) was 
used for color development. The kit came with a stock solution of secondary 
antibody against mouse/rabbit that was useful in our experiment to detect antibodies 




Diluted the crude protein extract at different concentration with TBS. Pre-
wetted the nitrocellulose membrane "NitroBind" (MSI, MA) with TBS. Placed the 
membrane on the gasket support plate and assembled the apparatus. Rehydrated the 
wells with TBS. 
Applied an equal volume (lOO i^L) of different concentration of antigen to 
the required wells. Spared wells for negative controls that were only blocking 
solution without antigen and with an antigen not cross-reacting with the primary 
antibody used. All samples and controls were done in duplicate. All the samples and 
controls were flowed through the wells by gravity because passive filtration was 
necessary for quantitative antigen binding. Washed the wells with an aliquot ofTBS 
equal to the original sample volume to each sample well. Added 200-300^L 
blocking solution to each well. Vacuum was not applied because it would lead to 
poor assay results. Washed the wells 3 times with 300^iL TTBS by partial vacuum 
suction and stopped once the TTBS had drained from all the wells. Applied lOOfiL 
of primary antibody and allowed gravity filtration. Applied vacuum to remove 
excess liquid. Washed the wells 3 times with 300fiL TTBS by partial vacuum 
suction and stopped once the TTBS had drained from all the wells. Applied 100^L 
of secondary antibody (1:1000) and allowed gravity filtration. Washed the wells 3 
times with 300^L TTBS by partial vacuum suction and stopped once the TTBS had 
drained from all the wells. Incubated lOOfiL of the streptavidin^iotinylated-HRP 
complex (1:400) and allowed gravity filtration. Washed the wells 3 times with 
300|iL of TTBS under partial vacuum. Removed the membrane from the apparatus. 
Washed the membrane twice with TBS to remove excess Tween 20 on the 
membrane. Prepared the 3，3，-diaminobenzidine tetrahydrochloride (DAB) solution 
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by dissolving a DAB tablet (Sigma, Cat#D5905) in lOmL ofTBS and added 100^L 
ofO.3% hydrogen peroxide. Applied the DAB solution to develop the color at room 
temperature and observed the signal development until the intensity was right and the 
background was low. To stop the color development, washed the membrane with 
plenty of distilled water. Air-dried the membrane and scanned the image into the 
computer for further image analysis. Measured the pixel density of the signals and 
plotted the pixel density against the dilution factor. 
2.6.2.2.3. Sodium Dodecylsulphate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) 
The SDS-PAGE was used to separate the crude brain protein extract into 
different size. The gel was saved for the Westem blotting. The proteins were 
transferred to the membrane for the immuno-detection of the acidic fribroblast 
growth factor. 
2.6.2.2.3.1. Materials and Reagents 
Electrophoretic Buffer, 10X 
The constituents of the solution were 0.25M TRIZMA® BASE (Sigma, 
T1503), 1.92M glycine (Sigma, Cat#G7032) and l%(w/v) sodium dodecylsulfate 
(Sigma, Cat#3771). 
Resolving Gel Buffer, 2X 
Dissolved 30.28g of TRJZMA® BASE and 2.0g of SDS into 950mL of 
distilled water. Adjusted pH to 6.8 and made the final volume of lL. 
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Stacking Gel Buffer, 2X 
Dissolved 90.84g of TRIZMA® BASE and 2.0g of SDS into 950mL of 
distilled water. Adjusted pH to 8.8 and made the final volume o f lL . 
30% Acrvlamide Solution (Gel Solution) 
Dissolved 146.0g of acrylamide (Sigma, Cat#A3553) and 4.0g of Bis-
acrylamide (Sigma, Cat#M7279) in 500mL of MQ water. Wrapped the bottle with 
aluminum foil and stored at 4°C. 
30% Ammonium Persulfate 
Dissolved 0.06g of Ammonium persulfate (Mannheim Boehringer, 
Cat#100735) into 200^iL ofMQ water. 
Sample Loading Buffer, 2X 
Dissolved 0.757g ofTRIZMA® BASE, 2.0g of SDS, and 10.0g of sucrose 
into 90mL ofMQ water. Mixed well before adding the 5.0mL of 2-mercaptoethanol 
(Sigma, Cat#M7154) and lg of bromophenol blue (Sigma, Cat#B8026). Made the 
final volume to lOOmL. 
Sample Preparation 
Mixed equal volume of sample with samples loading buffer. Heated the 




SDS-PAGE was performed using Mini-Protean II Electrophoresis Cell (Bio-
Rad). 15% resolving polyacrylamide gel and 4% stacking polyacrylamide gel were 
used to separate the proteins. The preparation of the gels followed the standard 
procedures. The 10-well comb was inserted into the stacking gel. The setup was put 
into the electrophoretic buffer tank. After the stacking gel polymerized, removed the 
combs and loaded samples and protein markers (Bio-Rad, Cat#161-0324) into the 
wells inside the buffer tank. Ran the SDS-PAGE at constant voltage of 80V until the 
blue dye front was about 1 cm above the glass bottom edge. 
2.6.2.2.4. Western Blotting 
2.6.2.2.4.1. Materials and Reagents 
Protein Transfer Buffer, Stock 
The constituents of the solution was 300mM TRIZMA® BASE (Sigma, 
Cat#T8404), 2M glycine (Sigma, Cat#G8898). Adjust pH to 8.3 and store at 4�C. 
Protein Transfer Buffer, Working 
Diluted 100mL of Stock Protein Transfer Buffer with 700mL of MQ water. 
Added 200mL of methanol (Merck, Cat#106009) and made the final volume of lL 
with MQ water. The buffer was stored at 4°C. 
Stock Tris Buffer Saline (10X TBS) 
Dissolved 12.11g TRIZMA® BASE，90.0g sodium chloride in lL of 
distilled deionized water. 
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Working Tris Buffer Saline (TBS) 
100mL of 10X TBS mixed with 850mL of distilled deionized water. 
Adjusted the pH to 7.4 and made the final volume to 1000mL. 
Blocking Solution 
Dissolved 50g skimmed milk powder in lL of TBS. The solution could be 
stored at 4°C for several months. 
Primary and Secondary Antibody (Diluent: Blocking solution) 
Primary Antibody: aFGF (R&D Systems, Cat#AB-32-NA).(Dilution: 1:400) 
Secondary Antibody: From the Immunoblotting Kit (Zymed, USA). 
Detection Svstem 
"Immunoblot-AP" Kit for rabbit primary antibody (Zymed Laboratories, 
Inc., USA, Cat#96-7142) was used to detect the primary antibody on the membrane. 
The kit included chromogen/substrate solution (BCIP/NBT) and alkaline 
phosphatase conjugated secondary antibody against rabbit IgG. 
2.6.2.2.4.2. Procedures 
After the protein samples were resolved, the gel was removed from the 
setup for electroblotting. Pre-wetted the nitrocellulose membrane "NitroBind" (MSI, 
MA), Whatman filter papers and sponges with Protein Transfer Buffer. Placed one 
sponges and filter paper on the transparent Acrylic Pressure Plate of the sandwich. 
Carefully put the polyacrylamide gel on the filter paper. Placed the wet membrane 
on the gel in one step. Removed the trapped bubbles and Place the filter paper and 
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the sponge on the membrane. Clamped the assembly and put into the electroblotting 
tank. The polyacrylamide gel side of the sandwich was faced to the cathode of the 
electroblotting setup. Used constant 150mA to transfer the protein to the membrane 
with periodically change of ice pack for cooling for 1.5-2 hours. 
Conditioned the membrane and washed away excessive SDS on the 
membrane with TBS for 5 minutes. Blocked the membrane with blocking solution 
for 2 hours at room temperature. Drained the blocking solution. Incubated the 
desired primary antibody (of suitable dilution) ovemight at 4°C. Washed the 
membrane several times with plenty of TBS for 30 minutes. Incubated with 
secondary antibody against rabbit IgG for 30 minutes. Washed the membrane 
several times with plenty of TBS for 30 minutes. Added the substrate solution for 
color development to visualize the location of the primary antibody. The color was 
developed in 10 minutes. 
2.6.2.3. Antibody to Basic Fibroblast Growth Factor 
To verify the antibody to basic fibroblast growth factor, 
immunohistochemistry and dot blot were employed. All the procedures in both 
experiments were followed as described in Section 2.6.2.2 for acidic fibroblast 
growth factor. The primary antibody was against basic fibroblast growth factor 
instead of acidic fibroblast growth factor. 
2.6.2.4. Antibody to Transforming Growth Factor-pi 
To verify the antibody to transforming growth factor-pl, immunohisto-
chemistry and Westem blotting were employed. All the procedures in all the 
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experiments were followed as described in Section 2.6.2.2 for acidic fibroblast 
growth factor. The primary antibody used in the procedures was against 
transforming growth factor-pi instead of acidic fibroblast growth factor. For the 
transforming growth factor-pl, brain tissue and growth plate were used in the 
immunohistochemistry. 
In Westem blotting, the brain tissue extract was replaced by the total serum 
protein in protein separation and protein transfer. The detection system for the TGF-
pl was different from that in antibody to aFGF. Streptavidin^iotinylated-HRP 
complex amplification kit (DAKO, K0492) and ECL detection system (Amersham, 
Cat#RPN3004) were used for the visualization of the binding of the primary 
antibody. The procedures different from the aFGF were briefly described below. 
After the incubation of secondary antibody in Westem blotting, washed the 
membrane thoroughly with plenty of TBS for 30 minutes. Then the membrane was 
soaked in ECL solution for 2 minutes. The membrane was covered by a Fuji medical 
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Figure 2.1: Surgical procedures for fracture healing and distraction 
osteogenesis 
At the left tibia, four transosseous holes were drilled through the aid of plastic 
template and the drill guide (panel A). After the insertion of the four Stainnman 
pins, an open sub-periosteal osteotomy was performed at the mid-shaft of the 
tibia by an oscillating saw (panel B). After sutured the wound of the osteotomy 
site (panel C), the Stainnman pins were interlocked onto the external distraction 
fixator (panel D). 
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Figure 2.2: Configuration of the self-design external distraction fixator 
The configuration of different views was shown in separate panels. Panel A is 
the front view; panel B is the rear view; panel C is the side view; and the panel 
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Figure 2.3: Representative radiographs of distraction site with the 
aluminum step wedge 
The radiography was taken weekly with the aluminum step wedge for the 





^ ^ ^ i ^ t ^ 4 : ; . ^ H B z z Z Proximal Region 
m ^ ^ r n 
^ | I ^ K ^ | MiddleRegion | p _ 
^ • K . ^ o ^ H - - . 
^ ^ ^ ^ ^ ^ ^ ^ ^ f ^ ^ ^ ^ ^ H Distal Region 
^ M I 
Distal Tibia 
Figure 2.4: Radiograph of the distraction callus was divided into three 
different zones 
Standardized x-ray radiography of the osteotomized tibia with aluminum step 
wedge in anteroposterior projection was taken weekly after the operation. In 
the measurement of the radiodensity of the distracted callus, three different 






3.1. Animal Model 
In this study, two main groups of animals were operated with standardized 
osteotomy procedures and fixed with the identical external fixation device. For the 
fracture healing group, the animals did not receive any distraction. For the 
distraction osteogenesis group, the animals were distracted after a seven-day latency 
period. Sub-groups of animals in both groups of fracture healing and distraction 
osteogenesis are shown in Table 3.1. 
3.1.1. Fracture Healing Animal Model 
24 goats were used in the fracture healing group (Table 3.1). All the 
animals could tolerate to bear the external fixator during the experiment period 
without any health problem or infection. From the weekly radiograph, fracture callus 
could be observed at the fracture site. The plain x-ray images were used for the 
BMD measurement. The animals were then euthanized at various time points. The 
fracture callus was removed for histology and immunohistochemistry. 
3.1.1.1. Radiography of Fracture Healing 
The representative radiographs were shown in Figure 3.1. At week 2 after 
the fracture, no obvious radiodense fracture callus was observed around the fracture 
site. One month after fracture, a partially calcified callus was formed around the 
fracture site. The callus continued to calcify in the following weeks. At week 8 after 
the fracture, the fracture gap had not been fused. Although the fusion was observed 
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at week 12 post-fracture, the morphology of the tibia at the fracture site did not seem 
to restore to the original. In addition to the 24 animals in the study, one extra animal 
was followed up for 24 weeks. By the end of the 24 weeks, the fracture was 
completely healed. The cortex and the medullary canal were restored (Figure 3.1: 
Week 24). 
3.1.2. Distraction Osteogenesis Animal Model 
24 animals were done for the distraction osteogenesis group (Table 3.1). All 
the goats were able to tolerate the distraction without any non-union or health 
problem during the experiment period. Newly generated callus under the distraction 
force could be observed from the weekly radiographical follow-up. The plain x-ray 
images were used for the BMD measurement. The animals were euthanized at 
various time points. The distraction callus was removed for histology and 
immunohistochemistry. 
Since in the distraction osteogenesis a latency period of 7 days was required 
for subsequent distraction applied, there was no difference between the fracture 
healing group and the distraction osteogenesis group at this time point after operation 
(Week 1). The two groups shared the same set of animals at Week 1 post-fracture for 
the study, which was described in section 3.1.1. 
3.1.2.1. Gross Morphology ofDistraction Osteogenesis 
The gross morphology of the distraction osteogenesis at different time 
points was shown in Figure 3.2. During the latency period, the fracture gap was 
filled with hematoma and no obvious bony callus was seen. Only soft tissue was 
around the fracture site. During the distraction period (Week 2 to Week 5 after 
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osteotomy), the gross morphology of the distraction site changed with time. After 
two weeks of distraction, soft callus around the distraction site was observed. The 
periphery of the distraction callus was vascularized. When the distraction came to 
the end at week 5 after osteotomy, a large bony callus was formed to bridge the 
distraction site. The orientation of either the soft tissue in week 3 post-osteotomy or 
the bony callus in week 5 post-osteotomy was parallel to the direction of the 
distraction force. After the distraction stopped, the distraction callus continued to 
grow till week 7 post-operation. The peripheral vascularization was subsided and the 
callus was consisted of mainly bony tissue. As seen at week 8 and week 12 post-
operation, the size of the callus shrank and the callus was remodeled to normal bone. 
After the distraction stopped for eleven weeks, the width of the callus returned to that 
of the normal tibia. The distraction callus looked almost like the original cortical 
shaft. 
3.1.2.2. Radiography of Distraction Osteogenesis 
From the weekly radiography, distraction callus bridging the distraction site 
was observed. During the latency period and the first week of distraction (week 1 
and week ‘ 2 post-osteotomy), no obvious mineralized tissue was seen on the 
radiographs (Figure 3.3). In this model, the typical radiodense columns of 
mineralized tissue near the osteotomy sites and the radiolucent zone were observed 
during the distraction period (week 5). The mineralization of the callus after the 
distraction was parallel to the columns formed in the distraction period. The external 
portion of the callus was increased in width and also mineralized. The middle 
radiolucent zone was diminished by the third week after distraction stopped (week 
8). The mineralization pattem was from the ends of the osteotomy site towards the 
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center of the distraction callus. Remodeling of the distraction callus was taken place 
at week 12 post-osteotomy. The diameter of the callus gradually returned to the 
diameter of the adjacent cortical ends. . In the study, one extra animal was done for 
24 weeks. By the end of the twenty-four-week healing, the morphology of the 
regenerated callus was very similar to the normal tibia (Figure 3.3). 
3.2. Bone Mineral Density (BMD) Measurement 
The weekly radiography of both animal groups was taken with an aluminum 
step wedge. The radiodensity of the callus formed at the fracture gap and the 
distraction callus was calibrated with the thickness of the aluminum step wedge. 
3.2.1. In Fracture Healing 
From the histology, the fracture site at week 1 post-fracture consisted of 
only fibrous clot and hematoma. No bony tissue was formed at the fracture site. 
Hence, the BMD values at week 1 post-fracture were not included in this study. The 
BMD of the fracture callus formed at the fracture gap during fracture healing was 
shown in Figure 3.4A. The pre-operation BMD value of individual goat was shown 
at the week 0, which served as baseline. During the first four weeks, the BMD ofthe 
fracture callus at the osteotomy site did not have any dramatic increase. The BMD 
was gradually increased and reached the peak at week 7 or week 8 after the 
osteotomy. Then the BMD gradually dropped back to the initial value. 
The BMD change was also expressed as the percentage change of BMD 
based on the BMD value at the third week after the osteotomy (Figure 3.4B). The 
BMD value at week 3 after osteotomy as the baseline was chosen because there were 
missing data at the week 2 after osteotomy during the very early stage of experiment. 
56 ‘ 
Results 
The percentage changes of individual goat could not be calculated if the BMD of the 
second week after osteotomy were used. By fitting a trendline into the graph, a 
parabola-like curve was obtained (Figure 3.4B). The figure showed that the most 
rapid increase of BMD was between week 3 and week 6 post-fracture. The BMD 
stopped to increase by week 9 after the osteotomy. Afterward, the BMD of the 
fracture callus entered into a declining phase that the BMD dropped slowly until 
week 12 post-fracture. 
3.2.2. Distraction Osteogenesis 
The changes of BMD at three different regions of the distraction callus in 
distraction osteogenesis were shown in Figure 3.5. The three measured regions were 
proximal, middle, and distal portion of the distraction callus as defined in the 
methodology (Figure 3.5A, B, C). The pre-operation BMD value of individual goat 
was plotted at the week 0. 
During the distraction period, the BMD of all three regions of the distraction 
callus was below the pre-operation BMD value. An indistinct peak of BMD was 
observed in the individual goat. For example, the peak of BMD at the proximal and 
distal region of the distraction callus of Goat GA9 happened at 8 weeks after 
osteotomy. The middle region of the distraction callus had a slightly different story. 
No obvious peak was observed during the whole process. The BMD of the middle 
region increased gradually. 
However, when the BMD value was translated to the percentage change of 
BMD based on the BMD at week 2 after osteotomy, a different picture of the 
individual region was observed. The changes ofthe proximal and distal region were 
very similar (Figure 3.6A, C). During the distraction period, the BMD of these two 
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regions started to increase. Once the distraction was stopped, the increase of BMD 
was more rapid within the period of week 5 and week 8. After the distraction for 
four weeks, the peaks of BMD in both regions were reached and then started to 
decrease. The maximum percentage increase in both proximal and distal region was 
about 80% of the BMD value at week 2 after osteotomy. The curve of the 
percentage change of the proximal region could be almost superimposed to that of 
the distal region. 
The percentage of the BMD in the middle region of the distraction callus 
was different from the proximal and distal region (Figure 3.6B). A delay of BMD 
increase was observed during the distraction period. The rapid increase of the BMD 
at the middle region was observed after the distraction stopped for a week. This was 
different from the proximal and distal region in which the BMD was increased 
rapidly after the distraction stopped. Since there was a delay in BMD increase, the 
maximum increase of the percentage of BMD was happened between week 5 and 6 
after the distraction stopped. 
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3.3. Bone-specific Alkaline Phosphatase Activity in Goat Serum 
In addition to the study of the mineralization of the regeneration processes, 
the cellular activity of both processes was investigated in term of the serum BALP 
activity. Weekly samples of blood were taken from individual animal. The BALP 
activity was measured by the auto-analyzer after wheat germ lectin precipitation. 
3.3.1. Fracture Healing 
To normalize the individual variation between different goats, the per-
operation serum BALP activity was defined as the baseline in the study. All the 
subsequent measurement was presented as the percentage of the baseline value. 
(Figure 3.7). The percentage ofBALP activity in serum was dropped during the first 
week after operation. The day 3 and day 5 value were significantly lower than the 
baseline. The BALP activity at the first week after osteotomy was lower than that 
before the operation. During the second week of fracture healing, the BALP activity 
raised to the first peak that was about 25% of initial value. At the subsequent weeks 
until week 6 post-fracture, the BALP activity was higher than the baseline value. 
After six weeks ofhealing, the BALP activity returned to its baseline value. 
3.3.2. Distraction Osteogenesis 
Similar to the fracture healing group, the values of the serum BALP activity 
was normalized by the pre-operation BALP activity in distraction osteogenesis 
group. The percentage change of serum BALP activity was shown in Figure 3.8. 
Before the distraction started, the serum BALP activity was generally dropped about 
30% of the initial value (week 0). The values were significant lower than the 
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baseline value. As the distraction started, the BALP activity increased gradually and 
maintained at a plateau for the whole period of distraction. When the distraction 
stopped, the activity was declined slowly and back to the initial value at the seventh 
week after distraction stopped. 
3.4. Serum Osteocalcin Measurement 
In this study, the de novo osteocalcin in serum of both groups was 
measured. It is a biochemical indicator of bone turnover. Weekly measurement of 
the serum osteocalcin concentration was done by ELISA kit. 
3.4.1. Fracture Healing 
The serum osteocalcin concentration was normalized with the per-operation 
concentration of serum osteocalcin. In Figure 3.9，the percentage change of the 
concentration was shown. At week 1 after operation, the osteocalcin concentration 
decreased 60% of the initial value. After the drop at the initial week, the change of 
osteocalcin concentration showed a rising trend. The osteocalcin was continuous to 
increase in the whole period of the healing process. At week 12 post-fracture, the 
osteocalcin concentration was about 100% greater than the baseline value. 
3.4.2. Distraction Osteogenesis 
The baseline ofthe osteocalcin measurement of distraction osteogenesis was 
also set at the pre-operation value. Similar to the fracture healing group, the 
osteocalcin concentration of the distraction osteogenesis group dropped in the first 
week after operation and it was about 50% of the baseline value (Figure 3.10). 
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During the distraction period, from week 1 to week 5 post-fracture, it raised and 
maintained at a level. However, this level of concentration was below the initial 
value measured at the day of operation. After the distraction stopped, the osteocalcin 
dropped back to the concentration level at the first week after osteotomy. 
3.5. Histology 
3.5.1. Fracture Healing 
The histology around the fracture site was changed along the healing period. 
At different time points, different features such as intramembranous ossification and 
endochondral ossification were observed. 
One week after fracture, fibrous clot and hematoma were observed at the 
fracture gap. The fibroblast-like mesenchymal cells from the periosteum were 
started to grow into the fracture gap. Along the fractured cortical bone, a thin layer 
ofnew trabecular bone had been developed (Figure 3.11A). The mesenchymal cells 
derived from the thickened proliferating periosteum were differentiated to osteoblasts 
to form bone (Figure 3.11C). In between the ends of the new trabecular bone, soft 
callus mainly contained fibroblasts-like cells and mesenchymal cells bridged the 
fracture gap (Figure 3.11B). The soft callus and the periosteal tissue were well 
vascularized throughout and capillaries were visible over the fracture site. The 
intramembranous ossification around the cortex was continued in the healing 
process. In the medullary region, the mesenchymal cells from the bone marrow were 
granulated adjacent to the fracture site and started to invade the hematoma and the 
fibrous clot (Figure 3.11D). Like the periosteal bone formation, the endosteum was 
thickened and new trabeculae were formed along the cortex. Besides, the 
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observation of the change in the periosteum and endosteum, inflammatory respond 
was also observed. The inflammatory cells were found among the soft callus at the 
fracture site. 
At week 2 post-fracture, the fracture gap was still filled with fibrous clot. 
Hematoma around the fracture site was almost completely removed. At the 
periosteal side of the fracture site, the soft callus containing fibroblasts and 
mesenchymal cells was progressively enlarged (Figure 3.12A). The sub-periosteal 
bone formation was continued and more trabecular bone was formed along the 
fracture cortical bone (Figure 3.12B). The periosteal callus was vascularized except 
in the cartilaginous tissue. The cartilaginous tissue was observed right above and 
adjacent to the fracture site. The endochondral and intramembranous ossification 
were observed simultaneously. The fracture healing at week 2 post-fracture had 
entered the endochondral ossification phase (Figure 3.12C). 
Like the second week after osteotomy, residue of hematoma in the 
periosteal callus still remained at the week 3 post-osteotomy (Figure 3.12D). The 
fibroblasts mixed with mesenchymal cells had invaded to the fracture gap. 
Meanwhile, the periosteal trabecular bone along the cortical bone continued to grow 
and the size was bigger than that of pervious two weeks. The trabecular bone was 
fully covered by osteoblasts that were actively synthesizing the bone matrix. As the 
trabecular advancing towards the center of the callus, the soft callus including the 
fibrous and cartilaginous tissue was reduced in size. The cartilaginous tissue was 
undergone endochondral ossification to replace cartilage with bony tissue. In 
addition, the vascularization was very active in the periosteal callus. At the 
medullary region, the granulated tissue started to form bone. The hematoma and the 
fibrous clot had not been completely removed but were gradually replaced by the 
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granulated tissue and trabecular bone. The trabecular bone developed from the 
endosteum was getting larger and larger in the first few weeks after fracture. The 
circulation in the region was re-established by the formation of capillaries observed 
on the section. No cartilaginous tissue was observed in the medullary region during 
the first three weeks of the fracture healing process. 
At the week 5 post-osteotomy, a line of cartilaginous tissue was observed at 
the external callus adjacent to the fracture site and the trabecular bone along the 
cortical bone filled the whole periosteal callus (Figure 3.13A). The trabeculae near 
the cortical bone were thickened and less osteoblasts on the trabecular bone was 
observed. However, the woven bone near the periosteum contained many 
osteoblasts. By this time, the soft callus was mostly replaced by the trabeculae and 
only very little was right at the fracture gap (Figure 3.13B). The trabeculae filled not 
only the periosteal space, but also the medullary region (Figure 3.13C). While new 
bone was formed surrounding the fracture site, the fractured cortical bone was 
undergone remodeling. 
Three weeks later (week 8 post-osteotomy), the fracture cortical bone had 
fused with the transverse lamellae of new bone formed at the fracture gap. However, 
the straight edge of the cut was still visible. The resorption of the periosteal callus 
and the endosteal callus had been started. Large resorption cavities appeared in the 
callus. The number of osteoblast on the trabecular was further reduced. The 
resorption at the medullary region was more obvious that in one case that the 
endosteal callus was almost removed (Figure 3.14A&B). 
The histology ofthe fracture at week 12 post-osteotomy was very similar to 
that at week 8. The remodeling of the callus around the fracture site was extensive, 
but the edge of the saw cut could be identified. Larger resorption cavities were 
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observed at the periosteal callus and almost all the endosteal callus had been 
resorbed. The bone marrow now filled the medullary canal and mixed with some 
granulated tissues and some debris left from the resorption (Figure 3.14C, D, &E). 
The progressive change of the amount of osteoblast on the fracture callus was shown 
in Figure 3.15. The decreasing trend of the amount of osteoblasts could be observed. 
3.5.2. Distraction Osteogenesis 
Latency Period 
In the distraction osteogenesis group, the histology at the first week after the 
osteotomy was the same as that of the fracture healing group because the distraction 
osteogenesis required a latency period before the commencement of distraction 
(Figure 3.11). 
Distraction Period 
After one week of distraction, the fibrous clot and the hematoma at the 
osteotomy site had not completely removed yet. The fibrous tissue developed in the 
latency period was expanded along the direction of distraction as a bridge between 
the cortical ends and replaced the hematoma. The newly formed trabecular around 
the cortical bones was also elongated along the distraction force (Figure 3.16A). The 
trabeculae were advancing toward the center of the distraction callus. Active 
intramembranous ossification was observed at the edge of the advancing woven 
bone. This active bone forming front was called the active ossification front. In the 
medullary region, the new trabecular bone formed at the endosteum was also 
advancing to the center of the distraction callus (Figure 3.16B). Meanwhile, under 
the distraction force the granulated tissue was expanded (Figure 3.16C). The 
distraction callus in a whole at this stage was mainly soft tissue. The only hard tissue 
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found was around the cortical bone. Although the callus had been under a tension 
force, the alignment of the fibroblast-like mesenchymal in the soft callus was still in 
an unorganized way. 
When the distraction started for two weeks, the trabecular around the 
cortical and at the endosteal side was continued to advance towards the center of the 
distraction callus. Although the trabecular bone form the periosteum and the 
endosteum had been grown around the tips of the fractured cortical bones, a fibrous 
tissue was still attached the cortical ends (Figure 3.17A). At the tip of the fractured 
cortex, small amount of hematoma and the fibrous clot were still observed. 
However, the soft callus containing fibroblast-like cells had replaced the fibrous clot 
and the hematoma at the medullary region. The orientation of the long axis of the 
fibroblast-like cells was parallel to the distraction force as well as the alignment of 
the collagen (Figure 3.17B). At the middle of the distraction callus, the ossification 
front extended from both osteotomy ends was observed. Moreover, the fibrous tissue 
was vascularized (Figure 3.17C). At the periphery of the distraction callus, cartilage-
like tissue was observed (Figure 3.17D). 
At the edge of the periosteal and endosteal trabecular bone, the 
intramembranous ossification was very active and the cell density was higher than 
the vicinity. Moreover, the new trabecular bone was well covered with active 
osteoblasts. In some cases, some cartilaginous tissue was found at the edge of the 
periosteal trabeculae. Some of the cartilaginous tissues had been undergone 
endochondral ossification. The proliferating periosteum continued to play a role in 
supplying undifferentiated cells for the rapid bone formation. 
At the end of the distraction period that was four weeks after the distraction, 
the histology was very similar to the previously mention in the second week of 
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distraction. Although the newly formed osseous tissue was grown in size, the fibrous 
tissue attached to the tips of the cortical bone was still observed and the axis of the 
cells and the collagen alignment were in the same direction of the distraction force 
(Figure 3.18A). The advancing bone forming fronts of the trabecular bone became 
very close to each other, but a certain amount of fibrous tissue was generated under 
the distraction (Figure 3.18B). The blood vessels and the fibroblast-like cells in the 
soft callus were aligned with the direction of the distraction force (Figure 3.18C). 
Even the cells involved in the intramembranous ossification were also in an order 
manner that was parallel to the distraction force (Figure 3.18D). In addition, 
microcolumn of trabecular bone aligned with the distraction force was frequently 
observed (Figure 3.18E). The trabecular bone that was formed at the first three 
weeks after the osteotomy was thickened (Figure 3.20). 
Consolidation Period 
In the consolidation period, the trabeculae in the distraction callus continued 
to extend toward the center fibrous interzone. By three weeks after the distraction 
stopped, the fibrous interzone of the distraction callus was almost replaced by the 
trabeculae and the remaining area was transformed to cartilage-like structure (Figure 
3.19 A&B). This tissue was converted to trabeculae by endochondral ossification. 
The osteoblastic activity was further subsided when compared with that in the 
distraction period (Figure 3.20). That was shown by the less number of osteoblasts 
covering the trabecular bone. As the number of osteoblasts decreased, the trabeculae 
were now covered with many bone-lining cells. It was more often to observe 
osteoclasts on the trabeculae. At the middle of the distraction callus, bone formation 
was still active because of the transformation of the cartilaginous tissue to bony 
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tissue by endochondral ossification. Adjacent to this central ossification zone, the 
trabecular bone surrounding the fractured corteices was more compact. 
At the seventh week in the consolidation period (Figure 3.19 C&D)，the 
central cartilaginous zone was no longer existed. The whole callus was composed of 
trabecular bone and was under remodeling process. Most of the trabeculae were in 
microcolumns parallel to the distraction force except the trabeculae at the central 
ossification zone formed after the distraction stopped. 
3.6. Verification of Primary Antibody Used in the Study 
In this section, various methods were used to verify the feasibility of 
applying the commercially available primary antibodies in the goat tissue. The 
primary antibodies used were originally against either bovine antigen or human 
recombinant antigen. Although the growth factors are very conserved across species, 
there is possibility that the polyclonal antibody cannot recognize the antigen from 
other species. Therefore, tests for the specificity in goat tissue were performed. 
3.6.1. Antibody to Acidic Fibroblast Growth Factor 
3.6.1.1. Dot Blot 
The brain protein extract was blotted on the nitrocellulose membrane. Then 
the membrane was incubated with primary and then secondary antibody. Afterward, 
an avidin-biotin complex system was used to detect the secondary antibody. After 
color development, the colored membrane (Figure 3.21) was captured by image 
analyzer. The pixel density of the dots on the membrane was analyzed. The results 
were presented as a graph of pixel density against the dilution factor (Figure 3.22). 
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A linear relationship was observed between the pixel density and the concentration 
of antigen. This indicated that the antibody was proportional bound to the antigen 
according to the concentration of the antigen. In other words, the primary antibody 
was specific to the antigen. 
3.6.1.2. Western Blotting 
Figure 3.23 showed the Westem blot for the aFGF in goat brain protein 
extract. Two bands were observed at the molecular weight of 18kDa and 22kDa 
which were the molecular weight of aFGF. This further proved that the specificity 
was constrained to the aFGF. 
3.6.1.3. Immunohistochemistry of Goat Brain and Growth Plate 
The immunostaining for aFGF was observed in the neurons of goat brain 
tissue (Figure 3.24) (Stock et al., 1992). For the localization of aFGF in the goat 
growth plate, the staining was observed at the resting chondrocytes and the 
hypertrophic chondrocytes (Figure 3.25) (Jingushi et al., 1995). 
These results also supported the specific of the primary antibody to aFGF 
since it had been reported that aFGF has two different molecular weight (18kDa and 
22 kDa) and was localized in brain and growth plate. Thus, the primary antibody 
may also be used in the goat fracture healing and distraction osteogenesis sections. 
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3.6.2. Antibody to Basic Fibroblast Growth Factor 
3.6.2.1. Dot Blot 
The nitrocellulose membrane was treated with similar procedures as for the 
anti-aFGF antibody. The colored dots were observed on the nitrocellulose 
membrane and were captured by image analyzer (Figure 3.26). A linear relation 
between the pixel density and the dilution factor of the goat brain protein extract was 
found (Figure 3.27). This indicated that the primary antibody against bFGF was 
specific to the antigen. 
3.6.2.2. Immunohistochemistry of Goat Brain and Growth Plate 
The antibody to the bFGF stained the chondrocytes at the resting, 
proliferating, and the hypertrophic zones of the goat growth plate. In addition, the 
antibody also stained extracellular matrix of the ossification zone (Figure 3.28). For 
the immunostaining of the goat brain, the antibody also stained specifically the 
neurons and blood vessels (Figure 3.29) 
These results implied that the antibody was also specific to the goat bFGF 
since it has been reported that bFGF was present in the growth plate and brain 
(Jingushi et al., 1995; Cordon-Cardo et aL, 1990). 
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3.6.3. Antibody to Transforming Growth Factor-pi 
3.6.3.1. Western Blotting 
The Westem blotting of the goat serum protein using the anti-TGF-pi 
antibody revealed a 25kDa band (Figure 3.30). The active TGF-pl is a 25kDa 
peptide. Therefore, the primary antibody is also specific to the goat TGF-pl. 
3.6.3.2. Immunohistochemistry of Growth Plate 
The anti-TGF-pi antibody was localized intracellularly at the chondrocytes 
of the resting and the hypertrophic zones of the goat growth plate (Figure 3.31). It 
had been shown that TGF-pl was present in the chondrocytes in the resting and the 
hypertrophic zone of rat growth plate (Jingushi et al., 1995). 
These results showed that the anti-TGF-p 1 antibody was also specific for 
the goatTGF-pi. 
3.7. Localization of Growth Factors in Fracture Healing and 
Distraction Osteogenesis 
From the pervious section, the primary antibodies for aFGF, bFGF, and 
TGF-pi had been verified to be applicable on the goat tissue. Paraffin sections of 
fracture healing and distraction osteogenesis at different time points were obtained 
for the immunohistochemistry. After the application of the primary antibody, the 
localization of the growth factors was visualized by the avidin^iotin complex-HRP 
system. The horseradish peroxidase in the system reacted with the chromogen and 
produced a brownish end product. This result was combined with the histology 
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described in the previous section 3.5 to deduce the possible functions of the growth 
factors involved in the fracture healing and distraction osteogenesis. 
3.7.1. Acidic Fibroblast Growth Factor 
3.7.1.1. Fracture Healing 
At the first week after fracture, the inflammatory response was observed. 
The inflammatory cells mixed in the fibrous tissue stained strongly for aFGF (Figure 
3.32). The osteoblasts and the pre-osteoblasts at the newly developing woven bone 
along the cortex demonstrated moderate immunostaining for aFGF (Figure 3.33A). 
However, some periosteal cells stained weakly and some were none (Figure 3.32C). 
The fibroblast-like cells and the mesenchymal cells adjacent to the fracture site 
stained weakly for aFGF (Figure 3.32E). 
In the second week post-fracture, the osteoblasts in both periosteal and 
medullary callus only exhibited weak immunostaining. However, the osteocytes in 
both new and old trabecular bone demonstrated aFGF staining where as the pre-
osteoblasts at the bone formation front stained for aFGF (Figure 3.34). At the 
cartilaginous tissue, the chondrocytes laid at the edge showed a moderate signal for 
aFGF (Figure 3.35). The fibroblast-like mesenchymal cells in external and 
medullary callus also moderately stained for aFGF. 
At week 3 post-fracture, the osteocytes in the woven bone and the 
trabeculae continued to show the moderate immunostaining for aFGF. The 
cartilaginous tissue, at this time, had not been completely replaced by the bony 
tissue. The chondrocytes at the edge of the cartilaginous tissue stained moderately. 
The staining in the fibroblast-likes cells and the mesenchymal cells was between 
moderate and weak. Two weeks later (Week 5 post-fracture), a few osteoblasts 
stained faintly for aFGF as well as the periosteal cells and the mesenchymal cells. 
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However, the osteocytes in the callus stained moderately for aFGF. The staining at 
this time was minimal. In the remodeling period (Week 8 and 12 post-fracture), the 
osteocytes stained weakly and the osteoblast showed no staining for aFGF (Figure 
3.36). 
3.7.1.2. Distraction Osteogenesis 
In the latency period, the osteoblasts and the pre-osteoblasts on the newly 
formed woven bone at the ossification front along the fractured cortex were stained 
moderately for aFGF. The periosteal cells in the proliferating periosteum 
demonstrated only a weak staining for aFGF. The fibroblast-like mesenchymal cells 
above the fracture site weakly stained. Comparatively, the medullary fibroblast-like 
mesenchymal cells around the fibrous clot and the hematoma had a moderate signal 
for aFGF. The pre-osteoblasts in the medullary region stained weakly. When the 
distraction started, the moderate aFGF staining was localized in osteocytes of the 
trabecular bone. The endosteum, osteoblasts and the fibroblast-like mesenchymal 
cells stained faintly for aFGF. During the whole distraction period from week 2 to 
week 5 post-osteotomy, only the osteocytes and the periosteal cells exhibited a 
moderate staining for aFGF (Figure 3.37). Other cells such as osteoblasts, per-
osteoblasts, and mesenchymal cells were with little or no staining for aFGF. At the 
boundary of the newly developed trabecular bone, the aligned bone forming cells 
faintly stained (Figure 3.8). Moreover, during the distraction, cartilaginous tissue 
was observed in two out of four cases. The edge of the cartilaginous tissue showed 
the presence of the aFGF (Figure 3.39). In the consolidation period (Week 8 and 
12) , t h e f i b r o u s t i s s u e w a s t r a n s f o r m e d t o t rabecu lar b o n e a n d c a r t i l a g i n o u s t i s s u e 
was observed at the middle of the distraction callus. The periosteal cells and the 
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osteocytes at the distraction callus became weakly stained for aFGF. The staining 
for aFGF at the osteoblast were sparingly observed (Figure 3.40 A&C). At week 3 in 
the consolidation period (Week 8 post-osteotomy), aFGF was localized in the 
peripheral chondrocytes of the cartilaginous zone but not the hypertrophic 
chondrocytes (Figure 3.40E). 
The summary of the immunohistochemsitry of aFGF during the fracture 
healing and distraction osteogenesis was shown in Table 3.2A&B. 
3.7.2. Basic Fibroblast Growth Factor 
3.7.2.1. Fracture Healing 
Immunohistochemistry revealed that the strong signal for basic fibroblast 
growth factor (bFGF) in the one-week-old fracture callus was at the osteoblasts and 
the pre-osteoblasts. The osteoblasts on the newly formed woven bone of the 
periosteal and medullary callus were stained intensely for bFGF (Figure 3.41). 
Adjacent to these osteoblasts at the bone forming front of the periosteal callus, the 
pre-osteoblasts also stained for bFGF. Moreover, in the medullary region, a strong 
signal of bFGF was localized at the endosteum adjacent to the fracture site (Figure 
3.41). In contrast to the immunostaining of the endosteum, the periosteal cells 
demonstrated a moderate bFGF staining. Not all the periosteal cells exhibited the 
bFGF staining. The fibroblast-like cells in the fibrous tissue at the middle of the 
callus also stained for bFGF. 
At week 2 post-fracture (Figure 3.42), the trabecular bone along the cortex 
continued to grow in size. At the transitional zone from densely cellular 
mesenchymal cells to woven bone in both external and medullary callus, the 
osteoblasts as well as the pre-osteoblasts continued to show strong intracellular 
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Staining for bFGF. The fibroblast-like mesenchymal cells, which found in the 
region, was also demonstrated strong staining. From the histology, the cartilaginous 
tissue appeared in the 2-week-old fracture callus. The chondrocytes at the edge of 
the cartilaginous tissue demonstrated strong bFGF staining. However, the cells at the 
central area of the cartilaginous tissue did not stained for bFGF. Moderate bFGF 
staining was observed at the periosteal cells. During the whole period of fracture 
healing, bFGF staining in the osteocytes was observed occasionally. At week 3 after 
fracture, the pre-osteoblasts on the transitional zone of the periosteal callus still 
stained strongly for bFGF. The other cell types that also stained strongly at this time 
point included the chondrocytes at the edge of the cartilaginous tissue and the 
mesenchymal cells in the fibrous tissue (Figure 3.43). The osteoblasts only stained 
moderately in periosteal and medullary callus. The staining for bFGF at the 
periosteal cells was subsided to a weak intensity. At week 5 post-fracture (Figure 
3.42), the osteoblasts on the new woven bone at region of intramembranous 
ossification stained moderately for bFGF. Although the pre-osteoblasts in the 
periosteal callus were not seen, it was observed in the medullary callus. The 
medullary per-osteoblasts stained moderately. Similarly, the fibroblast-like 
mesenchymal cells in the fibrous tissue exhibited a moderate staining for bFGF. In 
the remodeling phase of the fracture healing (week 8 to 12 post-fracture; Figure 
3.44)，the staining for bFGF at the osteoblasts was weak or no staining in both 
periosteal and medullary callus. 
3.7.2.2. Distraction Osteogenesis 
Like the first week after fracture in fracture healing group, the osteoblasts 
and the pre-osteoblasts in the latency period exhibited a strong bFGF staining in both 
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the external and medullary callus. The periosteal and the mesenchymal cells were 
just moderately stained. During the distraction period (Figure 3.45 and 3.46), the 
strong staining for bFGF at the osteoblast and the per-osteoblast was maintained 
while the periosteal cells, osteocytes and the fibroblast-like mesenchymal cells 
stained moderate. It was observed that the cartilaginous tissue was present in the 
external callus (Figure 3.47). The chondrocytes at the edge of the cartilage stained 
moderately. In the consolidation period (week 8 to 12; Figure 3.48)，the bFGF 
staining in osteoblasts and pre-osteoblasts was gradually reduced from moderate to 
weak signal. In week 8 post-osteotomy, the chondrocytes at the central cartilaginous 
zone showed a weak staining for bFGF. 
The summary of the immunohistochemsitry of bFGF during the fracture 
healing and distraction osteogenesis was shown in Table 3.3A&B. 
3.7.3. Transforming Growth Factor-pi 
3.7.3.1. Fracture Healing 
At the first week after fracture (Figure 3.49)，strong TGF_pi staining was 
observed at the osteoblasts, pre-osteoblasts, periosteal cells, and fibroblast-like 
mesenchymal cells in the external and medullary callus. At the week 2 and 3 post-
fracture, the chondrocytes at the edge of the cartilaginous tissue stained strongly for 
TGF-pi (Figure 3.50). The per-osteoblasts at the ossification front stained also 
strongly in week 2 post-fracture and reduced to a moderate signal by week 3 (Figure 
3.51). However, the moderate staining at the osteoblasts, periosteal cells and the 
fibroblast-like mesenchymal cells were maintained for these two weeks. The 
osteocytes also stained moderately in both external and medullary callus. When the 
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fracture healed for 5 weeks (Figure 3.52), the staining for TGF-pi was obviously 
subsided. Occasionally, fibrous tissue was still observed at this time, but the callus 
was mostly consisted of trabecular bone. The fibroblast-like mesenchymal cells in 
the tissue stained moderately. The periosteal cells, the osteoblasts and the osteocytes 
showed a weak staining for TGF-pi. This weak staining at the cells was also 
observed in the subsequent remodeling phase (Week 8 to 12 post-fracture). 
3.7.3.2. Distraction Osteogenesis 
The TGF_pi staining in the fracture callus at the latency period was similar 
to that of the fracture healing group at the first week post-fracture. During the 
distraction period (Figure 3.53 and 3.54)，the osteoblasts in the external and 
medullary callus demonstrated a strong staining for TGF_pi. At the end of the 
distraction period, the staining of osteoblasts was decreased to moderate and this 
moderate staining was lasted in the consolidation period (Week 8 to 12). The TGF-
pl staining of the osteocytes in the external callus during the distraction period was 
strong and then reduced to moderate by the end of the period. However, the 
osteocytes in the medullary callus stained strongly at the first week of distraction, but 
the signal intensity was reduced by the end of the distraction period. During the 
distraction, the periosteal cells stained weakly for TGF-pl and the fibroblast-like 
mesenchymal cells exhibited a moderate TGF-pl staining. The chondrocytes at the 
edge of the cartilaginous tissue stained strongly in the distraction period. In the 
consolidation period, although not all the osteoblasts stained for TGF-pi, the stained 
cells showed a moderate intensity (Figure 3.56). The chondrocytes in the central 
cartilaginous zone showed a strong staining for TGF-pl (Figure 3.55). Unlike the 
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chondrocytes, osteocytes in the external and medullary callus were further reduced to 
aweak TGF-pi. 
The summary of the immunohistochemsitry ofTGF_pi during the fracture 
healing and distraction osteogenesis was shown in Table 3.4A&B. 
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Figure 3.1: Typical radiographs of fracture healing from the day of 
operation (Day 0) to week 24 post-fracture 
At week 2 post-fracture, no obvious radiodense fracture callus was 
observed. A partial mineralized callus was formed by week 4 after 
osteotomy. At week 8 after fracture, the fracture gap had not been 
fused. At week 12 post-fracture, the fracture callus was undergone 
remodeling and the fracture gap was fused. One animal was followed 
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Figure 3.2: Typical gross morphology of the distraction callus in goat tibial 
distraction osteogenesis model 
The distraction period was from week 1 to week 5. During the distraction 
period, callus was formed and bridged the osteotomy ends. The callus size was 
continued to increase until week 8 post-osteotomy. By week 12 post-
osteotomy, the callus had undergone remodeling. At week 16 post-osteotomy, 
the distracted tibia had not fully remodeled back to normal tibia. 
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Figure 3.3: Typical radiographs of the progression of distraction 
osteogenesis 
Distraction Period was started at week 1 till week 5 post-osteotomy. During 
the distraction period, microcolumn of mineralized tissue was observed 
(arrow). In the consolidation period (week 8), a radiolucent zone at the middle 
of the distraction callus was observed. At week 12, the distraction callus was 
completely mineralized. By week 24 post-osteotomy, the remodel of the 
distraction callus was not yet completed. 
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Figure 3.4. Change of bone mineral density (BMD) of the fracture 
callus at the fracture gap during the fracture healing 
The BMD in term of the aluminum step wedge thickness (mm) was 
shown in panel A. The BMD of the fracture callus at the fracture gap 
increased gradually from week 2 to week 12. The percentage change of 
BMD based on the BMD at week 3 post-fracture was shown in panel B. 
A parabola-like curve could be induced form the scatter plot. An 
increasing trend of BMD was observed during week 2 to week 8. 
Afterward, the BMD of the fracture callus gradually decreased. 
81 
M r> - I n - Resa!ts 
A: Proximal Region 
I . • • • GA2 “餐 GA3 一 -• - GA4 x GA9 « GA141 
16 “^ _爾11^_漏_1^^,_敏 
14 - ^ ^ ^ ^ ^ ^ ^ ^ ^ 8 • •.. /•’•.,.， 
^^^^^^^^^^^^^^^ •  、•• ’• *•鲁 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ¾ / •、 / •、 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ¾ ¾ ^ ^ > ‘ • ‘ » 
12), ^ ^ ^ ^ ^ ^ ^ ^ .•‘ , ••-‘• •••. 
^^^^^^^^^^^^^^^^^^^^1 ‘  .• .… *.• ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H / .••• X •••••« «. • 
i l � � ‘ �� /" ^/-. .X……-«••_ 旦 II * ^< » * .：•< ••• • 
g , * • : / , • , . «•" * ^ .一-.、.~1.‘—.-1.-.一、 
I 8 . ‘ / • » • � � / / .;*?.^'-* ^ , Z 
S ？ . y - ' * ,产 y 
f ,^  •>：>'. -" ‘ ‘ Z 
\ ' ' y f ' i ^ . x ^ r r ' 
4- ^ ^ ^ ^ ^ ^ ^ ^ M 
A^^X'、、敏*^ 丨 
〜々冲—喊細命:, 
^ > 梦 � � *^f 3^^* � 
^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^^ ^ 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 Weeks Post-operation 
B: Middle Region 
| � 4 � GA2 •". GA3 - ‘ � GA4~ >< GA9 » GAlj] 
: | • 》 : . , . . - . 、 . . 、 ， . 、 
p ^!^多:::::-‘-., 
: „ 咖 ^ ) 
0 J -, _ . , ^ * , . . : ^ ; ^ . ^ ¾ . - …]......一…」 , ^ , 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 
Weeks Post-operation 
C: Distal Region 
| - -^- GA2 - • - GA3 - ^ - GA4 x GA9 _•«• GAi4] 
16 1 � � … / 
14_ 謹 糖 � . . . . . . • . . . . . . . � � . . . . . . . � 
百1'" M^^S^!^^'八 / ,;-:二-..丄."、'7,':..二..，:：^  
I ， • 终 必 恭 化 ： 二 . . - . . ' . . ' 、 、 : : > . ) 
i : : | ^ , 
: — ' - " " • 「――…、――_— . _—… .一 ― ― — . 
0 1 2 3 4 S 6 7 8 9 10 11 12 13 
Weeks Post-operation 
Figure 3.5: BMD changes of three different regions of the 
distracted callus in distraction osteogenesis. 
The shaded area is the distraction period. The pre-operation value of 
individual goat was shown at week 0. 82 
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Figure 3.6; Percentage change of BMD at different regions of the 
distracted callus in distraction osteogenesis. 
The shaded areas were the distraction period. 
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Figure 3.7. Scatter plot of the percentage change of serum BALP activity 
during fracture healing process. 
The mean values of the percentage change were shown in line. 
*At day 3 and 5, the BALP activity was significant difference from the initial 
value pre-operation (p<0.05). 
However, no statistically significant difference was found in the other time 
points (from week 1 to week 12). 
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Figure 3.8. Scatter plot of the percentage change of serum BALP activity 
during the distraction osteogenesis 
The shaded area indicated the distraction period from week 1 to week 5. 
During the distraction period, the BALP activity was increased. After the 
distraction stopped, the BALP activity slowly returned to the baseline. 
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Figure 3.9. Percentage change of serum osteocalcin concentration during 
fracture healing 
During the first week after fracture, the osteocalcin concentration was dropped. 
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Figure 3.10: Percentage change of serum osteocalcin concentration during 
distraction osteogenesis. 
During the first week after osteotomy, the osteocalcin concentration was 
dropped. During the course of the distraction osteogenesis, the osteocalcin 
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Figure 3.11: Photomicrographs of the fracture site at week 1 post-fracture 
A. At low magnification (16X), fibrous clot (C) was found adjacent to the 
fracture site (FS). A short distance from the fracture site, new trabecular bone 
was formed (T). Fibrous tissue (FT) was developed and surrounded the fracture 
site. B. At the fracture site (FS), the gap was filled with fibrous clot. The 
mesenchymal cells in the fibrous tissue (FT) started to invade the gap (lOOX). C. 
New trabecular bone (T) was formed by intramembranous ossification at the 
short distance from the fracture site (lOOX). D. At the medullary region next to 
the fracture site, granulated tissue (G) and hematoma (H) was observed. The 






Figure 3.12: Photomicrographs of the fracture callus at week 2 and week 3 
post-fracture (H&E) 
A. At week 2 post-fracture, adjacent to the developing trabecular bone (T) 
around the cortex, fibrous callus (FC) and proliferating periosteum (P) was 
observed (16X). B. The trabecular bone (T) was developed perpendicular to the 
cortical bone (horizontal arrow). In one fractured callus, fibrous callus (FC) was 
observed above the fracture site (FS) (16X). C. At week 3 post-fracture, 
cartilaginous tissue (C) was undergone endochondral ossification. Many blood 
vessels (horizontal arrows) were surrounding the cartilaginous tissue (16X). D. 
At week 3 post-fracture (16X), remaining hematoma (HM) in the medullary 
cavity was not completely removed. The endosteal trabecular bone continued to 
develop. The granulated tissue (GT) and large blood vessels (BV) were 
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Figure 3.13: Photomicrographs of the fracture callus at the fracture site at 
week 5 post-fracture (H&E) 
A. The remnant of cartilaginous tissue was observed by the end of the 
endochondral ossification stage (arrows) (16X). B. At the fracture site, the gap 
was filled with trabecular bone. Adjacent to the fracture site, the soft callus 
had been replaced by woven bone (arrow) (16X). C. The medullary callus 
consisted of trabeculae at week 5 post-fracture and large blood vessel was 
observed adjacent to the fracture callus (16X). D. The trabecular bone (T) 
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Figure 3.14: Photomicrographs of the fracture callus adjacent to the 
fracture site at week 8 and week 12 post-fracture (H&E) 
A. At week 8 post-fracture, the fracture site (FS) was filled with osseous tissue. 
The cortical ends were under remodeling. Blood vessels (V) and the resorptive 
cavity were observed (16X). B. Although the fractured cortical ends were 
undergone extensive remodeling, the straight edge of the osteotomy was still 
visible (horizontal arrows) Resorptive cavities (R) and osteoblasts (oblique 
arrows)were observed(lOOX). C. At week 12 post-fracture, the fracture callus 
was under extensive remodeling. The large resorption cavities were observed 
(arrows) (16X). D. At the medullary cavity adjacent to the fracture site, the 
fracture callus (FS) was almost disappeared. Remnant of trabeculae was 
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Figure 3.15: Photomicrographs of the external fracture callus at different 
times after fracture (200X) 
The number of osteoblasts on the trabecular bone at week 8 post-fracture was 
less than the previous time points at week 3 and week 5 post-fracture. 
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Figure 3.16. Photomicrographs of distraction callus of distraction 
osteogenesis after one week of distraction (H&E) 
A. Low magnification (16X) of the distraction callus at the osteotomy site was 
shown. Trabecular bone (T) was formed around the cortical ends. The 
distraction site was consisted of fibrous clot (FC) and fibrous tissue (FT). B. 
The trabecular bone (T) around the cortical ends started to advance toward the 
center of the distraction callus. The mesenchymal cells in the fibrous tissue 
(FT) were in an unorganized manner (50X). C. At the medullary region 
adjacent to the osteotomy site, granulated tissue was observed (50X). 
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Figure 3.17: Photomicrographs of distraction callus at the second week of 
distraction (H&E) 
A. At the osteotomy site, the external callus developed from the periosteal side 
(P) to the tip of the cortical end (C) (16X). B. At higher magnification (200X), 
the newly developed woven bone and the mesenchymal cells were aligned to the 
direction of the distraction force. At the end of the osteotomy end, resorption 
lacuna was observed (blue arrow). C. At the middle of the distracted callus, the 
newly formed trabecular bones (T) was advancing toward the center of the 
callus. The ossification center of intramembranous ossification was indicated 
(oblique arrows). In the soft callus, blood vessels were observed (vertical 
arrows) (16X). D. In the distraction callus, cartilaginous tissue (arrow) was 
observed and undergone endochondral ossification (78X). 
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Figure 3.18: Photomicrographs of distraction callus at the fourth week of 
distraction (H&E) 
A. After four week of distraction, fibrous tissue (arrow) was still attached to 
the cortical end at the distraction site. The callus was developed along the 
direction of the distraction force. B. At the middle of the distraction callus, the 
ossification center (OS) on the left was advancing towards the center of the 
callus. Blood vessels in the fibrous tissue on the right were observed (16X). 
C. High magnification (lOOX) of the fibrous tissue at the center of the 
distraction callus showed that the area was vascularized. D. During the 
distraction, the cells at the ossification center of intramembranous ossification 
was aligned with the direction of the distraction force (lOOX). E. High 
magnification of the newly developed trabecular bone showed that the new 
bone was formed in microcolumn and covered with active osteoblasts during 





Figure 3.19: Photomicrographs of distraction callus in the consolidation 
period of distraction osteogenesis (H&E) 
A. At week 3 after distraction stopped (week 8 post-osteotomy), cartilaginous 
interzone (CC) at the middle of the callus was observed. The trabecular bone 
was thickened (16x). B. Safrainin 0 staining of the distracted callus at week 3 
after distraction stopped was shown. The cartilaginous tissue was stained red 
(16x). C. After the distraction stopped for 7 weeks, the central cartilaginous 
tissue of the distraction callus was replaced by trabecular bone. The 
development of the trabecular bone was parallel to the distraction force. (16X). 
D. Distraction callus in week 7 after distraction stopped. The matured 




K M ^^m m^ 
s •-• V X 4 ^ ^ v ；.：; 
I^ ',B: week 5 post-oste^to^ . ( . :二 




^ 声 - ^ ^ ^ ‘ , ^ ^ 一 ： - --y- % ^ ^ 
C: week 8 ^ o B t ^ t ^ e ^ y ^ ^ ^ 國 
Figure 3.20: Photomicrographs of the external distraction callus at 
different time points during distraction osteogenesis (200X). 
During the distraction period (week 1 to week 5), many active osteoblasts were 
covering the trabecular bone (A and B). After the distraction stopped for 3 
weeks (C)，the number of osteoblasts on the trabecular bone was similar to that 
in the distraction period. 
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Figure 3.21: Dot blot assay for the specificity of the primary antibody 
against acidic fibroblast growth factor 
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Figure 3.22: Dot blot assay on aFGF standard and goat brain 
protein extract 
A. The relationship between gray value and the dilution factor of the 
standard was shown. B. The relationship between gray value and the 
dilution factor of the brain extract was shown. The primary antibody 
used was against bovine acidic fibroblast growth factor. The linear 
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Figure 3.23: Western blot of the goat brain extract using immuno-
detection system for aFGF 
The primary polyclonal antibody was against acidic fibroblast growth factor. 
Note the 18kDa and 22kDa protein bands were the molecular weight of aFGF 
that reported in literature. The dot blot and Westem blot results showed that 
the primary antibody was specific to goat acidic fibroblast growth factor. 
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Figure 3.24: Immunohistochemistry of goat brain for aFGF 
Positive staining was observed in the neurons (N). It had been reported 
that fibroblast growth factors were found in these cell types. The 
negative control omitting the primary antibody was shown in panel B 
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Figure 3.25: Immunohistochemistry of goat growth plate for aFGF. 
A. aFGF staining was observed in chondrocytes at hypertrophic (lower arrow) 
and resting zones (upper arrow) of goat growth plate (50X). C. At high 
magnification (200X), aFGF staining at the chondrocytes in the proliferative 
zone was observed. The negative controls omitting the primary antibody for 
aFGF were shown in panel B and D. 
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Figure 3.26: Dot blot of goat brain extract for the antibody to basic 
fibroblast growth factor 
The left column was the bFGF standard in different dilution and the right was 
the goat brain protein extract at different dilution. As the concentration was 
diluted, the intensity of the dots decreased in both standard and protein extract. 
Different controls were also shown. The results showed that the antibody was 
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Figure 3.27: Dot blot assay on bFGF standard and goat brain 
protein extract for the primary antibody to bFGF 
A. The relationship between gray value and the dilution factor of the 
standard was shown. B. The relationship between gray value and the 
dilution factor of the brain extract was shown. The primary antibody 
used was against bovine basic fibroblast growth factor. The linear 
relationship showed that the primary antibody is specific to a protein in 
the brain protein extract. 
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Figure 3.28: Immunohistochemistry of bFGF in goat growth plate. 
A. The brown staining was observed at the matrix of the ossification zone and 
in the chondrocytes of the hypertrophic zone (arrows). C. bFGF staining was 
also observed in the chondrocytes at the resting zone of the growth plate 
(arrows). The primary antibody used was against bovine basic fibroblast 
growth factor. The negative control omitting the primary antibody was shown 
in panel B and D. It has reported that the bFGF was expressed by cells in 
hypertrophic and resting zone of the growth plate. The presence of bFGF in 
the ossification zone was also reported before. Combined with the previous 
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Figure 3.29: Immunohistochemistry of bFGF in the goat 
brain 
A. The bFGF staining was localized at the neurons (N) of the 
goat brain. (lOOX). B. The negative control was done by 
omitting the primary antibody for bFGF. It has been reported that 
the neuron in brain expresses bFGF. This result confirmed that 
the primary antibody can be used to in goat sample. 106 
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Figure 3.30: Western blotting of goat serum total protein for TGF-
P1 
The primary polyclonal antibody was against rhTGF-P 1. The single 
band at 25kDa was observed. This band corresponded to the molecular 
weight of active TGF-P 1. This implied that the primary antibody was 
specific to TGF-p 1 protein. 
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Figure 3.31: Immunohistochemistry of TGF-pl in goat growth plate 
A. TGF-pl staining was localized in the resting, proliferating, and hypertrophic 
zone of the growth plate (16X). At higher magnification (200X), the TGF_pi 
expressed in the resting chondrocytes (C). D. The proliferating and 
hypertrophic chondrocytes (arrows) were stained intracellularly for TGF_pi 
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Figure 3.32: Immunohistochemistry of aFGF in the inflammatory cells of 
the fracture callus at week 1 post-fracture 
At the initial stage of fracture healing, inflammatory cells were observed at the 
fracture site. A. The aFGF staining was localized at the inflammatory cells at 
the external fracture callus (arrows) (lOOX). C. At the medullary region, the 
inflammatory cells also stained for aFGF (arrows) (lOOX). The negative 
controls omitting the primary antibody were shown in panel B and D. 
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Figure 3.33: Immunostaining for aFGF in fracture callus at week 1 post-
fracture 
A. The aFGF staining was observed at the mesenchymal cells (MSC) and at the 
osteoblasts of the newly developing trabecular bone (arrows). (lOOX). C. At the 
first week after fracture, the periosteum was proliferated. The periosteal cells 
were stained for aFGF. E. At another location of external callus, aFGF staining 
was observed at the mesenchymal cells and the per-osteoblasts (lOOX). The 
negative control omitting the primary antibody was shown in panel B and D. 
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Figure 3.34: Immunohistochemistry of aFGF in the fracture callus at week 
2 post-fracture 
A. Strong staining for aFGF was observed at the osteocytes ( ^ ) . The 
osteoblasts on the trabecular bone were stained weakly for aFGF (vertical 
arrows) (200X). C. At the newly formed bone, the osteocytes stained strongly 
for aFGF ( ^ ) . The aFGF expression was also observed at the per-osteoblasts 
(double arrows) at ossification center (0) (lOOX). The negative control omitting 
the primary antibody was shown in panel B and D. 
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Figure 3.35: Immunohistochemistry of aFGF in the cartilaginous tissue of 
the fracture callus at week 2 post-fracture 
A. At week 2 post-fracture, chondrogenesis was occurred in the external callus. 
The chondrocytes (C) in the cartilaginous tissue were stained for aFGF. 
However, no staining was observed in the hypertrophic chondrocytes (H). 
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Figure 3.36: Immunohistochemistry of aFGF in fracture callus at week 8 
and week 12 post-fracture. 
At week 8 post-fracture (A, 200X) and week 12 post-fracture (C, 200X), the 
fracture callus was mainly consisted of trabecular bone. The osteocytes 
(arrows) in the trabeculae were stained for aFGF. The osteoblasts on the 
trabecular bone were not stained for aFGF. The negative control omitting the 
primary antibody was shown in panel B and D. 
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Figure 3.37: Immunohistochemistry of aFGF in distraction callus during 
the distraction period of distraction osteogenesis 
A. During the distraction period (week 1 to week 5), the osteocytes (open 
arrows) in the distracted callus were stained moderately for aFGF (200X). C. 
At the periosteal distraction callus, the osteocytes (OC) were also stained for 
aFGF as well as the periosteal cells (vertical arrow) (200X). The negative 







Figure 3.38: Immunohistochemistry of aFGF of the aligned cells at the 
ossification center of the intramembranous ossification during distraction 
A. During the distraction period (week 1 to week 5), the trabecular bone was 
developed from the cortical ends and advanced towards the center of distraction 
callus. At the ossification center of the intramembranous ossification, the 
mesenchymal cells and the differentiated osteoblasts were aligned with the 
direction of the distraction force. These cells (arrow) were stained faintly for 




‘ V • 二 V^ - - •' - J -:-"3 � V -^ f, ^ -^  ”- - ' ^ 7； ^ 
« I -,%. \ V ， . )1 z -^ -w>^ '-. -^  - ..^ri%--. 
. A , ' - . 也 V � � v f * ‘ . ? " B � “ � ! ^ 二 ‘ - 》 . ； ^ ^ 
,::?、#[::‘• : % ， _ 
- ^ V ”二 • a f � . , 、 - 资 ， . 、 � \ y . > ^ W : m 
> - ' - \ ' ^ - ' ^ N , ^ r : 暴 ‘ ‘ . 、 , : : ： 、 、 � ^ ^ ' t ^ ^ - > ^ V :缺 
-i^'严 V. . i ' , — ‘ / 、.差…‘-—-^ ~ V -‘、--:义 
‘ ^ *9 ‘ ’ � — • ” - «» -*'' r � .， >•：. ‘ ‘^ , ： ..fr^ '^ 
‘ i^^�-, • • “ .'工 .-^,- :、\:、—-广二 ., :、、\. 
• 知 . - -『• - ‘� - .. *^ • c ) rrsr.、^ :^：^  /.、 
电 fc « 广、 . ‘ » ^ � . .�> u - ‘ . ：¾? _"a .>..,-
• ... V. » ^. ^ - V-. %. :.:?. ^ "• . -.^. V t "- ^ “ ^ .^ r--;' 
». - • *r. .一 „ . _ ,-, ’ ^ "S�>... ^ -. i^ & > .J -•-' 
. 一 . . ^ ,. .- � � ' ‘ . , _ V, ,丄. - ;¾ • ^ � ‘ : V • .- 冗.〜-、. <. , , r � V- „ •‘ ?J 
.�-, .- •• • - 4 : - �. V • � (; _ .-i^i^ .：••.,. c. • 
「 二 “ ^ ^ ， 二 了 -， i . . D ， .歌 : ? . —，.”.:...？.).開 
C r'j>. ‘ - mjB D ^ .^ . - ； , :. , 4 
“ " * ^ :¾:.:-*:- --- . . - • , : 、 . 」 . . , . i ‘ • 、 •'. .-. .'0、.:，^  -i 
‘• •'!, ‘ ：^ . , . ¾ ¾ '.:. . . .、 ^ ^、 > ^ _ 
,<e -.二 -、 . . ..、_ 
• … . . / - 祷了：.-.-'� ^"'WflS| 
- t ' ; - . t 二 . : | 暴 _ . - . m 
I “ 「 .：： ¥ ^ 仏 ' ^A:::h i 
: . - , .^  .稱 ‘ -
. I . . : 0 ^ 
• r r f : >••—、.： • 、 
« * , 
Figure 3.39: Immunohistochemistry of aFGF in cartilaginous tissue of the 
peripheral distracted callus during the distraction period 
A. and C. During the distraction period (week 3), the aFGF staining was 
localized in the chondrocytes (arrows) at the edge of the cartilaginous tissue. 
The negative controls were shown in panel B and D (200X). 
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Figure 3.40: Immunohistochemistry of aFGF in fracture cailus during the 
consolidation period of distraction osteogenesis 
A. and C. During the consolidation period (week 8 to week 12), the aFGF 
staining was localized in the osteocytes but not in the osteoblasts on the 
trabecular bone (arrows). E. During the consolidation period, the cartilage 
interzone was developed at the central region of the distraction callus. The 
aFGF was localized in the peripheral of the cartilage zone and the chondrocytes 
(arrow) were stained intracellularly for aFGF. The negative controls omitting 
the primary antibody were shown in panel B, D, and F (200X). 
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Figure 3.41: Immunohistochemistry of bFGF in fracture callus at the week 1 
post-fracture 
A. At low magnification (16X), the bFGF signal was observed adjacent to the 
cortical bone (C). B. At higher magnification (lOOX), the fibroblast-like 
mesenchymal cells from the proliferating periosteum were stained strongly for 
bFGF. The fracture site (F) was filled with fibrous clot only. C. The new woven 
bone was formed by the intramembranous ossification around the fractured 
cortical. The osteoblast and the per-osteoblasts (open arrows) differentiated from 
the proliferating periosteum (P) were stained strongly for bFGF (lOOX). E. The 
bFGF was localized at the endosteum (arrow) of the medullary callus (lOOX). F. 
The granulated tissue (horizontal arrow) and the endosteum (vertical arrow) 
showed the bFGF staining at the medullary callus adjacent to the fracture site 
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Figure 3.42: Immunohistochemistry of bFGF in fracture callus at week 3 and 
week 5 post-fracture 
A. At the week 3 post-fracture, the bFGF was localized at the fibroblast-like 
mesenchymal cells (lOOX). C. At the medullary callus, the osteoblasts and the 
per-osteoblasts at the ossification center (arrows) stained moderately for bFGF 
(lOOX). E. At week 5 post-fracture, the cartilaginous tissue at the external callus 
was replaced by the bone by endochondral ossification. The strong bFGF staining 
was localized at the newly formed trabecular bone (arrow) (lOOX). The negative 
controls omitting the primary antibody were shown in panel B, D, and F. 
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Figure 3.43: Immunohistochemistry of bFGF in cartilaginous tissue and 
trabecular bone during fracture healing 
A. At week 3 post-fracture, the bFGF staining was localized at the chondrocytes 
(vertical arrows) at the peripheral cartilaginous tissue formed adjacent the 
fracture site. The hypertrophic chondrocytes were not stained (lOOX). C. 
During the endochondral ossification, the chondrocytes (arrows) and the 
ossification zone (OZ) stained for bFGF (lOOX). E. Strong staining for bFGF 
was localized at both fibrous tissue and the new woven bone (arrows). The 
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Figure 3.44: Immunohistochemistry of bFGF in fracture callus at week 8 
and 12 post-fracture 
In the remodeling phase of fracture healing, the osteoblasts on the trabecular 
bone were stained weakly for bFGF (A, C, and D; 100X) (arrows). The 
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Figure 3.45: Immunohistochemistry of bFGF of the distraction callus at the 
second week of distraction 
A. During the distraction period, the osteoblasts on the distracted trabecular 
bone were stained strongly. (lOOX). C. At the ossification center of 
intramembranous ossification, the per-osteoblasts were also stained strongly for 
bFGF (200X). E. The ossification center (10) forming new woven bone (WB) 
stained strongly for bFGF (lOOX). The fibrous soft tissue (FST) was stained 
moderately for bFGF 
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Figure 3.46: Immunohistochemistry of bFGF at the distracted callus of 
distraction osteogenesis during the distraction period 
At the fourth week of distraction (week 5 post-osteotomy), the developing 
trabecular bone advanced towards the center of the distraction callus. At the tip 
of the trabecular bone, the cells were aligned with the distraction force and 
stained for bFGF (A: 40X; C: 100X). The osteoblasts and the per-osteoblasts 
continued to express bFGF. The negative controls omitting the primary 
antibody was shown in panel B. 
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Figure 3.47: Immunohistochemistry of bFGF in cartilaginous callus 
during the consolidation period of distraction osteogenesis 
A. During the consolidation period, the cartilaginous zone (CZ) was observed 
in the middle of the distraction callus. The edge of the cartilaginous area and 
the surrounding trabecular bone (T) were stained for bFGF. B. In the 
cartilaginous tissue, the hypertrophic chondrocytes (HC) were not stained for 
bFGF but the adjacent trabecular bone (T) and the chondrocytes were stained 
lightly for bFGF. C. High magnification (200X) of the chondrocytes at the 
edge of the cartilaginous tissue showed bFGF staining (horizontal arrows). 
The negative control omitting the primary antibody was shown in panel D. 
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Figure 3.48: Immunohistochemistry of bFGF in distracted callus during 
the consolidation period of distraction osteogenesis 
A. During the consolidation period (week 8 post-osteotomy), the osteoblasts on 
the thickened trabecular bone stained moderately for bFGF (arrows) (50X). C. 
The osteoblasts were not stained for bFGF at the seventh week after distraction 
stopped (arrows) (50X). The negative control omitting the primary antibody 
was shown in panel B and D. 
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Figure 3.49: Immunohistochemistry of TGF-pi in fracture callus at week 1 
post-fracture 
A. Strong TGF-pl staining was localized at the osteoblasts (oblique arrows) and 
the periosteal cells (vertical arrows) (200X). C. Strong TGF_pi staining was also 
localized at the pre-osteoblasts and the fibroblast-like mesenchymal cells (oblique 
arrows) (200X). The negative controls omitting the primary antibody were shown 
in panel B and D. 
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Figure 3.50: Immunohistochemistry of TGF_pi in the fracture callus at 
week 2 and 3 post-fracture. 
A. At week 2 post-fracture, cartilage was observed at the external callus. The 
chondrocytes at the periphery of the cartilage were stained strongly for TGF_pi 
(oblique arrows). The hypertrophic chondrocytes (HC) at the middle of the 
cartilage were not stained (lOOX). C. At week 3 post-fracture, the localization of 
TGF-pi was similar to the week 2 post-fracture staining. Only the peripheral 
chondrocytes were stained (arrows) (lOOX). The negative control omitting the 
primary antibody was shown in panel B and D. 
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Figure 3.51: Immunohistochemistry ofTGF_pi in fracture healing at week 
2 and 3 post-fracture 
A. At week 2 post-fracture, the osteoblasts (OB) on the newly formed woven 
bone were stained for TGF-pl as well as the mesenchymal cells (MSC) from the 
periosteum (200X). C. The TGF-pi staining was localized in the osteocytes 
(OC), osteoblasts (OB), and the mesenchymal cells (MSC) of the fracture callus 
(200x). E. Similar to week 2 post-fracture, moderate staining for TGF_pi was 
also localized in the periosteal cells (PC) and per-osteoblasts (POB) at week 3 
post-fracture (200X). The negative control omitting the primary antibody was 
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Figure 3.52: Immunohistochemistry of TGF-pi in fracture callus at week 8 
and 12 post-fracture 
A. At week 8 post-fracture, the fracture callus started to remodel. TGF-pl 
staining was localized only at the edge of periosteal callus (16X). C. At the 
outermost layer of the periosteal callus, the fibroblast-like mesenchymal cells 
stained for TGF-pi moderately (200X). D. During the remodeling phase, the 
osteoblasts on the trabecular bone was stained for TGF-pl as well as the 
osteocytes (200X). The negative control omitting the primary antibody was 
shown in panel B and E. 
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Figure 3.53: Immunohistochemistry ofTGF_pi in trabecular bone during 
distraction period of distraction osteogenesis 
A. & B. During the distraction period (week 1 to week 5), strong TGF_pi 
staining was localized at the pre-osteoblasts, osteoblasts, and osteocytes (arrow) 
(200X). C. The aligned cells at the ossification front (arrows) stained strongly 
for TGF-pi (200X). D. Strong staining for TGF-pi was also localized at the 
osteoblasts covering the newly formed trabecular bone (200X). The negative 
control omitting the primary antibody was shown in panel E. 
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Figure 3.54: Immunohistochemistry of TGF_pi in distracted callus of 
distraction osteogenesis during distraction period 
A. During the distraction, the microcolumn of trabecular bone was formed in the 
distracted callus. The osteoblasts on the trabecular bone exhibited strong 
staining for TGF_pi (40X). C. The TGF_pi staining was localized at the 
ossification center (0) of the developing trabecular bone. The cells in the area 
were aligned with the direction of the distraction force. (40X). D. The old 
trabecular bone that developed at the beginning of distraction period was 
thickened by the fourth week of distraction. It was aligned with the direction of 
the distraction force. The osteoblasts on the trabecular bone demonstrated the 
presence of TGF-pl (lOOX). The negative control omitting the primary 
antibody was shown in panel B. 
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Figure 3.55: Immunohistochemistry of TGF-pi in cartilage tissue during 
distraction osteogenesis 
A & B. During the distraction period, the islet of cartilage was observed at the 
peripheral area of the distracted callus. The TGF_pi staining was localized in 
the chrodrocytes (CC) but not the hypertrophic chondrocytes (HC) (200X). 
C. During the consolidation period, the chondrocytes (CC) and the ossification 
area (OA) of endochondral ossification at the cartilage interzone was stained for 
TGF_p 1 (200X). The negative control omitting the primary antibody was shown 
in panel D. 
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Figure 3.56: Immunohistochemistry of TGF-pl in distraction callus 
during consolidation period after the distraction stopped 
During the consolidation period (week 8 to week 12 post-osteotomy), the 
osteocytes were stained weakly for TGF-pi (arrows) (200X). B. Some 
osteoblasts on the trabecular bone were not stained (arrow) (200X). C. Some 
osteoblasts stained moderately for TGF_pi (arrow). TGF_pi was also present 
in the osteocytes ( ^ ) (200X). The negative omitting the primary antibody 
was shown in panel D. 
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“ Fracture Healing Distraction Osteogenesis 
Week(s) Post-operation Group Group 
1 4 4 
2 ~4 4 
3 ~4 4 
5 ~4 4 
8 4 4 
I2 4~~ 4 
Table 3.1: The distribution of the animal in both distraction osteogenesis and 
fracture healing group 
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Table 3.2A: Summary of the immunohistochemistry observation of aFGF in 
fracture healing 
External Callus: 
Post-operation Week 1 Week2 Week3 Week5 Week8 Week 12 
Osteoblasts ++/- +/- + +/- - -
Pre-osteoblasts ++ ++/- + NE NE NE 
Periosteal Cells +/- +/- + +/- NE NE 
Osteocytes NE ++ ++ ++ + + 
Chondrocytes NE ++ ++ NE NE NE 
Hypertrophic ^ ^ • . NE NE NE 
Chondrocytes 
Fibroblast-like + ++,+ + + NE NE 
Mesenchymal 
Medullary Callus: 
Post-operation Weekl Week2 Week3 Week5 Week8 Week 12 
Osteoblasts ++/- + + +/- NE NE 
Pre-osteoblasts +/- + + NE NE NE 
Osteocytes NE NE ++ + + NE 
Fibroblast-like +/_ 休 + + NE NE 
Mesenchymal 
+++: Strong Staining 
++: Moderate Staining 
+: Weak Staining 
- :Nega t ive Staining 
++/-: Some moderate/some negative staining 
+/-: Focal or questionable weakly positive 
NE: Not Exist 
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Table 3.2B: Summary of the immunohistochemistry observation of aFGF in 
distraction osteogenesis. 
External Callus: 
‘ � A ' z v . ' , � � / � ^ * ‘ ‘ � � “ � � 
Post-operation Week 1 Week 2 ^ Week3 > Week 5^  Week8 Week 12 
、<.' ‘ - A . .^  
r�" . / :� . . ’ , •.:、 ，..、..:..： 
— - - ；T~~y. Osteoblasts ++ + .+ + +/- +/-
Pre-osteoblasts ++ + + + NE NE 
Periosteal cells + + ++ ++ + + 
Osteocytes NE ++ + ++ + + 
Chondrocytes NE NE + NE ++ NE 
Hypertrophic 呢 NE • NE - NE 
Chondrocytes 
Fibroblast-like , , , , . , . . ^ \Tr： 
, , , , + + +/- +/- NE NE Mesenchymal 
Medullary Callus: 
Post-operation Week 1 Week2 Week3 Week5 Week8 Week 12 
Osteoblasts ++ + + + + +/-
Pre-osteoblasts + + + + NE NE 
Osteocytes NE ++ +;; ++ + + 
Fibroblast-like , , ^ . , , 、了广 \Tr 
, , , , ++ + + +/- NE NE Mesenchymal 
Week 1: Latency Period 
Shaded area: Distraction period 
Week 8 & 12: Consolidation Period 
+++: Strong Staining 
++: Moderate Staining 
+: Weak Staining 
- : N e g a t i v e Staining 
++/-: Some moderate/some negative staining 
+/-: Focal or questionable weakly positive 
NE: Not Exist 
136 
-^i^:^.jl*s 
Table 3.3A: Summary ofthe immunohistochemistry observation of bFGF in 
fracture healing 
External Callus: 
Post-operation Week 1 Week2 Week3 Week5 Week8 Week 12 
Osteoblasts +++ +++ ++ ++ +/_ +/_ 
Pre-osteoblasts +++ +++ +++ NE NE N£ 
Periosteal Cells ++ ++ + + NE NE 
Osteocytes NE +/- +/. +/_ _ _ 
Chondrocytes NE +++ +++ NE NE NE 
Hypertrophic • 
Chondrocytes ^ ^ _ _ NE NE NE 
Fibroblast-like , 
Mesenchymal + +++ 科+ ++ NE NE 
Medullary Callus: 
Post-operation Week 1 Week2 Week3 Week5 Week8 Week 12 
Osteoblasts +++ +++ ++ +++/++ +/. +/_ 
Pre-osteoblasts +++ +++ ++ ++ NE NE 
Osteocytes NE +/- +/- +/. _ NE 
Fibroblast-like 
Mesenchymal| ++ ++ ++ ^ NE NE 
+++: Strong Staining 
++: Moderate Staining 
+: Weak Staining 
-：Negative Staining 
++/-: Some moderate/some negative staining 
+/-: Focal or questionable weakly positive 
NE: Not Exist 
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Table 3.3B: Summary of the immunohistochemistry observation ofbFGF in 
distraction osteogenesis 
External Callus: 
Post-operation Week 1 Week 2 Week 3 Week 5 Week 8 Week 12 
Osteoblasts +++ +++ +++ +++ ++/_ +/_ 
Pre-osteoblasts +++ +++ +++ ++ ++ +/. 
..:y、，., • .^ , -. • 
• ."?》-«»."• • 
�v ) ：• ,^ 
Periosteal cells ++ ‘ 4HH- ++ +/. +/_ +/. 
.-��',..... -^-
Osteocytes NE + � ++ ++ ++ ++/• 
Chondrocytes NE NE ++ NE + NE 
S o Z c X ' NE NE _ NE - NE 
Fibroblast-like , , 
Mesenchymal ++ ++ ^ ^ NE NE 
Medullary Callus: 
Post-operation Week 1 Week2 Week3 Week5 Week8 Week 12 
Osteoblasts +++ +++ +++ +++ ++/_ +/_ 
Pre-osteoblasts +++ +++ +++ ++ ++ +/_ 
Osteocytes NE + ++ + ++ +/_ 
Fibroblast-like , , 
Mesenchymal ++ 州 - 叫 科丨-++" NE 
Week 1: Latency Period 
Shaded area; Distraction period 
Week 8 & 12: Consolidation Period 
+++： Strong Staining 
++: Moderate Staining 
+: Weak Staining 
-：Negative Staining 
+/-: Focal or questionable weakly positive 
++/-: Some moderate/some negative staining 
NE: Not Exist 
138 
Table 3.4A: Summary of the immunohistochemistry observation ofTGF_pi in 
fracture healing 
External Callus: 
Post-operation Week 1 Week2 Week3 Week5 Week8 Week 12 
Osteoblasts +++ ++ ++ + + ++/-
Pre-osteoblasts +++ +++ ++ NE NE NE 
Periosteal Cells +++ ++ ++ + + +/-
Osteocytes NE ++ ++ + + + 
Chondrocytes NE +++ +++ NE NE NE 
Hypertrophic ^ ^ • _ ^ ^ NE NE 
Chondrocytes 
Fibroblast-like 丄丄/xTr： xTir xm 
, , , , +++ ++ + ++/NE NE NE Mesenchymal 
Medullary Callus: 
Post-op. Week 1 Week2 Week3 Week5 Week8 Week 12 
Osteoblasts +++ ++ + + +/- NE 
Pre-osteoblasts +++ ++ + NE NE NE 
Osteocytes NE ++ ++ +/- +/- ++/NE 
Fibroblast-like 
, , , 1 +++ ++ ++ + NE NE Mesenchymal 
+++: Strong Staining 
++: Moderate Staining 
+: Weak Staining 
- :Nega t ive Staining 
+/-: Focal or questionable weakly positive 
++/-: Some moderate/some negative staining 
NE: Not Exist 
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TabIe 3.4B: Summary ofthe immunohistochemistry observation ofTGF_pi in 
distraction osteogenesis 
External Callus: 
Post-operation Weekl Week2 Week3 Week 5 Week8 Week 12 
Osteoblasts +++ +++ +++ ++ ++/_ ++/_ 
::-.:':,r ••. / • 
..:“.......，.."-• • ". • -“;<v ^ 
Pre-osteoblasts +++ +++ +++ • ^++ “ NE NE 
™~"™"~~"~~~*^~~~~~~—~~~" —^—^—^—^_^__^  ~««-^_««^_««_«____ __^__^_ *• - • . • 
Periosteal cells ++ + + + +/_ +,_ 
Osteocytes NE +++ +++ ++ + + 
Chondrocytes NE NE +++ NE +++ NE 
Hypertrophic . _ … 
Chondrocytes • NE _ NE - NE 
Fibroblast-like , , 
Mesenchymal +++ ^ ++ ++ NE NE ^ 
Medullary Callus: 
Post-operation Week 1 Week2 Week3 Week5 Week8 Week 12 
Osteoblasts +++ +++ +++ ++ ++ ++ 
Pre-osteoblasts +++ ++ +++ 4~f NE NE 
Osteocytes NE +++ ++ + + + 
Fibroblast-like 
Mesenchymal +++ ^ 付 ++ NE NE 
Week 1: Latency Period 
Shaded area: Distraction period 
Week 8 & 12: Consolidation Period 
+++: Strong Staining 
++: Moderate Staining 
+: Weak Staining 
- :Nega t i ve Staining 
+/-: Focal or questionable weakly positive 
++/-: Some moderate/some negative staining 






Since the establishment of the Ilizarvo's method in bone lengthening, the 
research of distraction osteogenesis was concentrated on clinical application, 
distraction procedures, and post-lengthening rehabilitation. Until recently, the basic 
mechanism of the bone formation under tensile force was explored by using various 
molecular biology techniques. The discovery of the bone derived growth factors 
further enhances the knowledge about the regulatory mechanism of different kinds of 
bone formation. Basically, intramembranous ossification and endochondral 
ossification are two types of bone formation described in the literatures. 
Intramembranous (or direct) ossification is considered the most primitive form of 
osteogenesis. In the process, bony trabeculae were formed by direct condensations 
of mesenchymal tissue. In contrast, endochondral ossification is an osteogenesis in 
which cartilage was formed as intermediate and then progressively replaced by bone. 
In this study, the bone formation activity and the expression of growth factor in the 
ossification process during fracture healing and distraction osteogenesis was 
investigated. The difference between the two processes during the time of distraction 
enhanced the understanding about the effect of tensile force on the regeneration of 
osseous tissue. 
4.1. The Biochemical Events in Fracture Healing 
According to the radiography and the histology, the standardized surgical 
procedures performed in this study could reproduce an open fracture fixation with 
the self-design external fixator. In fracture healing, the active ossification phase was 
observed during the first six weeks after fracture because the increasing rate of BMD 
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of the fracture site was faster than that in the subsequent period of healing process. 
After the BMD stopped to increase, the fracture callus entered the remodeling phase. 
This was consistent with the change of the bone forming markers that were BALP 
activity and osteocalcin. During the first six weeks post-fracture, the BALP activity 
was increased and the concentration of the serum osteocalcin was also raised 
gradually. These changes in bone forming markers during fracture healing process 
were also reported in the pervious reports (Lammens et al., 1998; Leung et aL, 1993). 
From the histology of the fracture callus at the first week after fracture, new 
woven bone was formed at the fractured cortex by direct condensation of 
mesenchymal cells form the periosteum. This implied that ossification was 
happened at the first week after fracture. This finding was observed until the fifth 
week after fracture. During this period of healing, cartilaginous tissue was also 
observed at the external callus beside the fracture site and the mineralization 
surrounding the cartilaginous tissue occurred. These observations implied that the 
intramembranous and endochondral ossification was happened in the fracture healing 
process. Compared with other fracture healing model in rat (Bonnarens, 1984; 
Bolander, 1992), the present goat model has certain similarities. The sequence of the 
different stages was (1) inflammatory response; (2) intramembranous ossification; 
(3) chondrogenesis; (4) endochondral ossification. 
In the first week after fracture, the fracture site was filled with fibrous clot. 
New woven bone was formed around the fractured cortex. However, the BALP 
activity and the serum osteocalcin were below the baseline. It may due to the small 
systemic effect of the localized bone forming activity during initial stage of the 
fracture healing. Besides the changes in bone formation markers, the growth factors 
had started their actions. The expression of aFGF in the inflammatory cells may 
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imply that the inflammatory response introduces this growth factor into the fracture 
site to attract more cells to invade the fracture. It has been shown that aFGF was a 
chemoattractant for the migration of microvessel endothelial cells (Stokes et al, 
1990). The aFGF could also act as a chemoattractant for the osteoprogenitor cells for 
the subsequent ossification (Buckley-Sturrock et al., 1989; Lind et al., 1995). In our 
fracture healing model, the expression ofbFGF and TGF_pi was demonstrated at the 
mesenchymal cells and the pre-osteoblasts of the center of intramembranous 
ossification. This suggests that both polypeptites may stimulate the proliferation of 
the osteoprogenitor cells and induce the osteoblasts to synthesize matrix. This 
observation was sustained during the subsequent callus formation. In addition, it was 
suggested that the angiogenic capacity of bFGF could help to promote the growth of 
blood vessels during fracture healing. This will provide nutrients for the bone 
forming cells to form new bone during the reparative process. Thus, the fracture 
callus can develop properly (Rodan and Rodan, 1992). 
During the chondrogenesis, simultaneous expression of the three growth 
factors at the chondrocytes surrounding the cartilaginous tissue. In the study of 
Jingushi et al (1995). aFGF injection stimulated cartilage enlargement in fracture 
healing. They suggested that aFGF induced proliferation of chondrocytes in the 
fracture callus and/or induced migration of chondrocyte progenitor cells into the 
fracture site. Moreover, they also showed that aFGF may also delay the maturation 
of the chondrocytes. That means the chondrocytes may delay their hypertrophy. In 
the present study, the expression of the aFGF in the chondrocytes at the peripheral 
cartilaginous tissue agrees with pervious observation by other researches. This 
implies the chondrocytes produce aFGF at the fracture site to regulate the 
chondrogenesis. In addition, the pervious study by Iwasaki et al. (1995) showed that 
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TGF-pi stimulated the chondrogenic differentiation of periosteum-derived 
mesenchymal cells in vitro. Thus, with this regulatory action on chondrocytes, the 
TGF-pi in the chondrogenesis phase may act as autocrine to stimulate the 
proliferation of the chondrocytes. Then the chondrocytes may lay down matrix for 
the endochondral ossification in fracture healing. However, stimulation on the 
growth of cartilaginous tissue alone is not enough for promoting healing of the 
fracture. The soft callus must be able to transform to bony tissue for the reparation 
of proper mechanical strength of the long bone. Therefore, the expression of bFGF 
in the cartilage and the mesenchymal cells surrounding the cartilaginous tissue may 
give a balance to the chondrogenesis and endochondral ossification. In many studies 
(Kwawaguchi et al., 1994; Nagai et al., 1995; Wang, 1996; Wang & Aspenberg， 
1996a)，bFGF was shown to accelerate fracture healing in animal models other than 
goat. For example, when one application of bFGF was delivered in a fibrin gel it 
increased the callus size, mineral content and mechanical strength in fractured 
fibulae in normal and diabetic rats (Kwawaguchi et al, 1994). Accompanied with the 
pervious results, our present observation of bFGF in the fracture callus suggests 
bFGF may prompt the mesenchymal cells surrounding the cartilaginous tissue to 
differentiate to bone forming osteoblasts. Thus, bFGF may regulate the 
endochondral ossification. The reparation of the mechanical strain at the fracture site 
required proper endochondral ossification and intramembranous ossification. 
Intramembranous ossification was observed from the first week until the 
fifth week after fracture in our goat model. In the medullary region, the callus was 
formed only by intramembranous ossification. This may due to the good blood 
supply in the medullary cavity. Brighton and Hunt (1991) reported that within a few 
hours after a fracture is sustained, there was loss of normal architecture of the bone 
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marrow elements, disappearance of blood vessels in the region adjacent to the 
fracture callus clot, and a reorganization of the cellular complement of the bone 
marrow in region ofhigh cellular density. In the region ofhigh cellular density, there 
appears to be a transformation of endothelial cells to polymorphic cells and these 
cells express an osteoblastic phenotype and begin to form bone within 24 hours after 
fracture. The microenvironment of the medullary cavity may be different from the 
periosteal side of the fracture. It has been hypothesized that cartilage forms in 
regions of low oxygen tension (Caplan and Koutroupas, 1973; Hallmann et al., 
1987). In in vitro studies by Bassett & Herrmann (1961) and Pawelek (1969)，the 
mesenchymal cells differentiated towards a chondrocytic phenotype under low 
oxygen tension influences. Furthermore, Brighton and Kreb (1972) found that 
oxygen tension was low in both the newly formed bone and cartilage. This may due 
to increased oxygen consumption by the large numbers of cells present. In the 
medullary cavity, the vascularization adjacent to the fracture site and the nutrients 
brought form the bone marrow acted as critical factors for the direct bone formation 
instead of through endochondral ossification. 
The growth factor expression at the intramembranous ossification was 
mainly concentrated on the center of ossification and the osteoprogenitor cells. 
Comparatively, the expression of bFGF and TGF_p 1 was more prominent in the 
fracture healing process. At the periosteal callus, the expression of bFGF was at the 
osteoblasts on the new woven bone and the mesenchymal cells from the periosteum. 
As a potent mitogen of many cell types, bFGF may stimulate the proliferation 
osteoblasts and the mesenchymal cells. Hence, the enhanced bone formation may 
due to increasing number of the osteoblasts capable of synthesizing bone collagen. In 
addition to the presence of bFGF at the ossification center, the TGF-pl was also 
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localized there. In the other studies (Centrell et al, 1992; Wrana et al, 1988), TGF-p 
was shown to have stimulatory action on collagen production and collagen gene 
expression. Thus, the expression of TGF-P 1 at the ossification center may stimulate 
the synthesis of bone matrix. Besides the stimulatory effect on the bone cells, TGF-
P1 can stimulate the in vitro periosteal cell proliferation (Hock et al, 1988). In the 
present study, the co-existence of bFGF and TGF-pl at the osteoblasts and the 
mesenchymal cells in fracture callus may imply their coordinated synergetic effect on 
active callus formation. 
The present observation of the biochemical events in the fracture healing 
model was very similar to the previous studies (Joyce et al., 1990c; Bolander, 1992; 
Lammens et al., 1998; Bourque et al., 1993). In addition to the investigation of the 
fracture healing, the model can also be modified to investigate the biochemical 
events in distraction osteogenesis because the same fixator was used in this study. 
Through the comparison of the reparative and the regenerative processes, the effect 
of the tensile force on the biochemical events in the distracting callus could be 
elucidated. 
4.2. The Biochemical Events in Distraction Osteogenesis 
The basic principles of distraction osteogenesis developed by Ilizarov has 
been well established and had a well defined niche in the practice oforthopaedics. In 
Ilizarov's study (1990)，the principles as stated in the introduction (chapter 1) are 
important to the proper formation of new bone with a widening distraction gap. By 
following the principles, one can generally perform a successful bone lengthening. 
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However, the biology of the mechanical strain on osseous tissue is not fully 
understood. 
In general, it is accepted the concept that mechanical strain modulates the 
bone cell metabolism. In the present study, the BALP activity increased quickly 
during the first week of distraction. The activity was sustained at a high level during 
the distraction period and the first week after the distraction stopped. This indicates 
that the osteoblastic activity was elevated during the application of tensile force. It is 
agreed with the in vitro results by pervious researchers. Delloye et al. (1990) has 
reported that progressive distraction on sectioned long bones can stimulate and 
maintain the osteogenic capacity of the cells present at the distraction site. In other 
in vitro studies, it has been shown that the mechanical strain can significantly 
increase osteoblast proliferation, the production ofTGF_pi, and the collagen mRNA 
in either osteoblast or osteosarcoma cell line culture (Brighton et al., 1991; 
Neidlinger-Wilke et al., 1994; Hoblbein et aL, 1995; Harter et al., 1995). 
The increase of BALP activity is also reflected in the increase of the BMD 
at the proximal and distal region of the distraction site. Before the BALP activity 
reached the peak by week 3 post-operation, the increase of BMD at the two regions 
was mild. After the BALP activity reached the peak, the increase of the BMD was 
fastest in the course of distraction osteogenesis. At the middle region of the 
distraction site, there was a delay in the increase of BMD during the distraction 
period. The raise of BMD occurred after the distraction stopped. From the histology 
of the distraction callus in our study, the middle of the distraction callus was mainly 
consisted of fibrous tissue and the ossification center of intramembranous 
ossification extended from the osteotomy site. It is possible that the middle zone was 
the area for the mesenchymal cells to differentiate and the differentiated cells such as 
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osteoblasts to proliferate. Therefore, it may imply that the middle region of the 
distraction site was the proliferative zone of mesenchymal cells. This is supported by 
Neidlinger-Wilke et al. (1994) and Aronson et al (1990). They showed that the 
mechanical force could stimulate osteoblast proliferation. 
The serum osteocalcin measurement in the study is different from the other 
report (Lammens et al., 1998). The serum concentration in different periods was 
below the initial value at the day of operation. Although the exact explanation 
cannot be put forward here, one possible explanation of the low level of osteocalcin 
is the initial high level of the osteocalcin of the adolescent goat. It has shown that 
high serum osteocalcin values occur during the pubertal growth spurt (Price et al, 
1980). The goats brought from the government slaughterhouse are for commercial 
use. Thus, it was known that the age of goat should not be older than one year old. 
Moreover, form the radiography of the goats, the growth plates of the long bones 
have not been closed. Hence, the goat may be in its young age, so it is not surprising 
that the initial osteocalcin was high. During the experiment period, the systemic 
osteocalcin dropped when the goats grew older. This declining magnitude of the 
osteocalcin was larger than the change of osteocalcin induced by distraction 
osteogenesis. Thus, the change of osteocalcin due to distraction osteogenesis was 
masked. In addition to this speculation, the study by Stanford et al. (1995) showed 
that the expression of osteocalcin was depressed in the osteoblast-like cell culture 
under a mechanical strain. The study may give rational to the low level of the serum 
osteocalcin measured in the distraction group. In the fracture healing group, we 
observed that the osteocalcin values were gradually increased during the 
experimental period. This supports that the animals are in the growth period 
although the fracture may affect the measurement of the serum osteocalcin. In our 
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model, the tensile force suppressed the expression of serum osteocalcin. 
During the distraction period, the cells at the distraction site were gradually 
aligned along the direction of the distraction force. The formation of the trabecular 
bone was also parallel to the distraction force. This is unlike the trabecular bone 
formed in fracture healing. In fracture healing, the trabecular bone formed around 
the cortex is perpendicular to the long axis of the fracture cortex. It is possible that 
the different mechanical environment affects the direction of growth (Buckley et al., 
1988). The fracture callus experiences a compression force and the force may 
translated to a tensile force towards the periosteum. Thus, along the outward tensile 
force, the trabecular bone was formed perpendicular to the long axis of cortex. 
Similarly to the fracture healing, the distraction force acting on the cells at the 
distraction site is parallel to the long axis of the tibia. Hence, the new osseous tissue 
is formed parallel to the distraction force. This study showed that the tensile force 
directed the orientation of the cells at the distraction site. 
In fracture healing process, the expression of bFGF and TGF_pi in 
osteoblast and per-osteoblasts was strong during the first two weeks post-fracture. 
Comparatively, the high expression of bFGF and TGF_pi in osteoblasts and per-
osteoblasts of the distraction osteogenesis was sustained during the distraction 
period. This may implies that the distraction force can induce the expression of these 
growth factors. This is supported by the in vitro study ofHolbein et al. (1995). They 
showed that the cyclic stretching significantly increased the production of active 
TGF-p in primary human osteoblast culture. However, in this study, the mechanical 
effect on the expression of the aFGF during the distraction osteogenesis is not very 
obvious; only minor increase of aFGF expression was observed in periosteal cells 
and osteocytes. This may imply that the role of the aFGF in this regeneration 
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process is not as important as the other two, bFGF and TGF-p 1. Although it has 
been shown that mechanical force can induce the production of these growth factors, 
the mechanism of signal transduction from the tensile force to the biosynthesis of 
growth factor is not clear and required further study. 
In distraction osteogenesis, the bFGF and TGF_pi was also localized at the 
center of intramembranous ossification of the periosteal and distraction callus. It has 
been discussed about the expression of the growth factors in osteoblasts and the 
mesenchymal cell at the periosteal callus in the fracture healing sections. The 
growth factors should have similar roles in the formation of the periosteal callus. 
Although the localization ofbFGF and TGF_pi was similar between fracture healing 
distraction osteogenesis, the difference was that during the distraction period the 
expression of both growth factors sustained at a higher level. This suggests that the 
tensile force applying on the distraction callus stimulate the expression of bFGF and 
TGF-pl in osteoblasts and mesenchymal cell. Moreover, during the distraction 
period, the bFGF and TGF-pl was expressed at the boundary between the newly 
formed woven bone and the soft fibrous tissue in the distraction callus. The amount 
of the growth factor at the boundary was higher than the vicinity. In addition to the 
implication of the stimulative effect of the bFGF and TGF_pi in the bone formation 
and cells proliferation as happened in the fracture healing, the upregulated expression 
may suggest these growth factors as chemoattractant for the mesenchymal cells and 
the endothelial cells. This is an important role in the distraction osteogenesis since 
the rapid growing osseous tissue required many cells to be recruit to the ossification 
center. As chemoattractants, bFGF and TGF-pi have been suggested to participate 
in the recruitment of osteoblasts during bone remodeling (Lind et al., 1995). bFGF, 
which was known to be essential for vascularization and involved in the neo-
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angiogenesis (Gospodarowicz et al., 1986) as well as blood supply in the distraction 
osteogenesis, is critical for proper ossification as stated by Ilizarov (Aronson, 1994). 
The presence ofbFGF in the distraction callus in our model is then not surprising. It 
is localized at the extracellular matrix and blood vessels. Thus, as an angiogenic 
factor, bFGF may promote the vascularization in the distracting callus. 
Increased production of serum TGF_pi in osteoblasts during the distraction 
osteogenesis has been reported (Lammens et al., 1998). However, the measurement 
reflected the systematic effect of the distraction osteogenesis. In this study, the 
increased expression of TGF-p 1 was found at the osteoblasts, pre-osteoblasts, and 
mesenchymal cells in the distracting callus. This change was different form that in 
our fracture healing model. During the fracture healing, the TGF-pi was up-
regulated in the first week post-fracture and was gradually declined subsequently. 
This give us better understanding not only on in situ expression of the TGF_pi in 
distraction osteogenesis but also the stimulatory effect of tensile force on the 
expression of growth factors. The TGF_pi as an autocrine may stimulate the 
osteoblasts to synthesize extracellular matrix and the proliferation of various cell 
types; in tum, the ossification rate is increased. TGF_pi was also expressed in the 
osteocytes during the distraction period. Its presence may stimulate the osteocytes to 
fUrther synthesize bony tissue. Therefore, under the influence of the mechanical 
strain during the distration period, the increased expression of TGF-pi in the 
distraction callus has a stimulatory role for massive new bone formation. 
The distinct spatial and temporal expression patterns of aFGF, bFGF, and 
TGF-pi in distraction osteogenesis clearly illustrates their regulatory roles in the 
bone regeneration process. From the observation during the distraction period, we 
found that the tensile force increase the bFGF and TGF-pi expression in distraction 
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callus. The signaling pathway from mechanical force to the up-regulated expression 
of the growth factors is unknown. Hence, further study is required to provide more 
information on the induction of the growth factor biosynthesis by tensile force. 
In summary, the comparison between fracture healing and distraction 
osteogenesis in our animal model elucidated the stimulatory effect oftensile force on 
osseous tissue during osteogenesis. During the application of tensile force, the 
expression of bFGF and TGF_pi was up-regulated. Through the increased 
expression of the growth factor, the stimulatory functions of the peptides induce the 
osteoblastic activity as well as the biosynthesis of the extracellular matrix. Thus, 
higher BALP activity during the distraction period was observed as well as more 
osteoblasts present in the distraction callus. Subsequently, the BMD increased 
rapidly after the distraction stopped. 
4.3. Limitations of the present study 
Although the present model has given us more information on the 
biochemical events of distraction osteogenesis in a higher animal, there are still some 
limitations ofthe present study. Since the animal used was caprine, different kinds of 
molecular probe may not be readily available as for rat or mouse model. Therefore, 
additional experiments are required to verify on the probe or antibodies prior to the 
actual application to the goat mode. 
Moreover, the age of the animals cannot be strictly controlled in the study. 
We can only define the rough stage of life of individual goat. The entire herd of 
experimental goats used in the study has not reach the stage of growth plate closure. 





Using goats in the study has the advantage of similar structure of the human 
long bone. However, the cost of maintaining the large experimental animal is 
expensive. To conduct this comprehensive study, the research team has already spent 
large amount of funding in the supply and maintenance ofthe goats. 
4.4. Future Study 
Like the investigation of Joyce et al. (1990) and Jingushi et al. (1990)，the 
effect ofthe administration of different growth factors on the distraction osteogenesis 
in this animal model may be examined to understand the action of individual peptide 
during the regeneration process. If one can further accelerate the rate of 
osteogenesis, it is possible to increase the rate of distraction to minimize the 
distraction period. Moreover, the consolidation phase in the distraction osteogenesis 
is relatively lengthy. To study the regulatory role of growth factors in remodeling 
can give insight to shorten the length of the consolidation period. Using ultrasound 
to stimulate the ossification and remodeling in distraction osteogenesis should be a 
potential modulator for future investigation. 
In the present study, the mechanical stimulation increases the expression of 
growth factors at the osteoblasts in the distraction callus. However, very little was 
known in the signaling pathway from the mechanical force to the biosynthesis of 
different macromolecules such as various types of growth factor and collagen. The 
signaling pathway ofFGFs has been studied in various cell culture systems (Yayon et 
al.，1991; Omitz, and Leder, 1992; Jaye et al.，1992). Therefore, the previous studies 
of the in vitro cell culture system provide information for exploring the signaling 







The involvement of growth factors in fracture healing has been known for a 
long time. This study further elaborated their distribution profile in the goat fracture 
model. Similar to other studies in rat and human, the expression of the three growth 
factors investigated in the present study was concentrated on the active ossification 
area such as the ossification center of intramemberanous ossification and the 
ossification area of endochondral ossification. This study combined with other in 
vitro studies showed that the bFGF and TGF-pi had stimulatory roles in the 
development of the bony callus during fracture healing. Meanwhile, aFGF had the 
regulatory role in the chondrogenesis during the endochondral ossification phase of 
fracture healing. Therefore, these three growth factors may be considered to use 
clinically for enhancement of the fracture healing. 
In distraction osteogenesis, our model showed that intramembranous 
ossification and endochondral ossification were involved in the rapid formation of 
bony callus. During the distraction period, the main type of ossification was 
intramembranous. After the distraction has stopped, the distraction callus entered 
into a consolidation phase in which the mode of ossification was similar to that in 
fracture healing. Endochondral and intramembranous ossification were taken part in 
the regeneration process. The involvement of the three growth factors investigated in 
the study was very similar to that in fracture healing. During the distraction period, 
bFGF and TGF_pi were expressed by the osteoblast and the mesenchymal cells at 
the ossification center of the intramembranous ossification. The expression was 
sustained in the distraction period while in fracture healing the bFGF and TGF_pi 
expression gradually decreased after the first week post-fracture. Similar to fracture 
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healing, aFGF was observed at the cartilaginous tissue in distraction osteogenesis. 
This study showed that the three growth factors played stimulatory roles in 
proliferation and differentiation of cells. Meanwhile, the secretion of extracellular 
matrix was also stimulated. These effects were reflected in the change of BALP 
activity and the bone mineral density. During the distraction period, the BALP 
activity was increased while the BMD increased after the BALP activity is highest. 
The effect of the tensile force in bone regeneration was investigated by 
comparing fracture healing and distraction osteogenesis. During the distraction 
period of distraction osteogenesis, a constant tensile force is applied to the osseous 
tissue. The immunohistochemistry of the growth factors showed that the tensile force 
could up-regulate the expression of these growth factors. The upregulated 
expression of growth factors promoted differentiation of the mesenchymal cells. 
These growth factors also stimulated the osteoblasts to proliferate and to increase 
bone-forming activity. Thus, the BMD increased rapidly from the last week of 
distraction period to the third week after the distraction has stopped. Moreover, the 
BALP activity was also increased during the distraction period. Although this study 
showed that the tensile force had stimulatory effect on osseous tissue in term of 
cellular activity and growth factor expression, the path of the mechanical stimulation 
resulting in stimulating the increase of growth factor expression was still unclear and 
requires further studies. 
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